DE10202065A1 - Use of organoboron compounds capable of reducing (hydro)peroxides to alcohols in cosmetic or dermatological compositions useful for preventing or treating (hydro)peroxide-induced skin damage - Google Patents
Use of organoboron compounds capable of reducing (hydro)peroxides to alcohols in cosmetic or dermatological compositions useful for preventing or treating (hydro)peroxide-induced skin damageInfo
- Publication number
- DE10202065A1 DE10202065A1 DE2002102065 DE10202065A DE10202065A1 DE 10202065 A1 DE10202065 A1 DE 10202065A1 DE 2002102065 DE2002102065 DE 2002102065 DE 10202065 A DE10202065 A DE 10202065A DE 10202065 A1 DE10202065 A1 DE 10202065A1
- Authority
- DE
- Germany
- Prior art keywords
- boron
- containing compound
- cosmetic
- formula
- peroxides
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
- 150000001875 compounds Chemical class 0.000 title claims abstract description 56
- 150000002978 peroxides Chemical class 0.000 title claims abstract description 53
- 239000002537 cosmetic Substances 0.000 title claims abstract description 29
- 150000001298 alcohols Chemical class 0.000 title claims abstract description 13
- 230000037380 skin damage Effects 0.000 title claims description 7
- 239000000203 mixture Substances 0.000 title abstract description 10
- ZZUFCTLCJUWOSV-UHFFFAOYSA-N furosemide Chemical compound C1=C(Cl)C(S(=O)(=O)N)=CC(C(O)=O)=C1NCC1=CC=CO1 ZZUFCTLCJUWOSV-UHFFFAOYSA-N 0.000 title 2
- 239000003963 antioxidant agent Substances 0.000 claims abstract description 19
- ZOXJGFHDIHLPTG-UHFFFAOYSA-N Boron Chemical compound [B] ZOXJGFHDIHLPTG-UHFFFAOYSA-N 0.000 claims abstract description 17
- 229910052796 boron Inorganic materials 0.000 claims abstract description 17
- 230000003078 antioxidant effect Effects 0.000 claims abstract description 14
- 150000002432 hydroperoxides Chemical class 0.000 claims abstract description 13
- 230000015572 biosynthetic process Effects 0.000 claims abstract description 10
- -1 alkaline earth metal salts Chemical class 0.000 claims description 78
- 238000002360 preparation method Methods 0.000 claims description 35
- MHAJPDPJQMAIIY-UHFFFAOYSA-N Hydrogen peroxide Chemical compound OO MHAJPDPJQMAIIY-UHFFFAOYSA-N 0.000 claims description 14
- 239000002516 radical scavenger Substances 0.000 claims description 10
- 125000003118 aryl group Chemical group 0.000 claims description 7
- 229910052784 alkaline earth metal Inorganic materials 0.000 claims description 6
- 125000000392 cycloalkenyl group Chemical group 0.000 claims description 6
- 125000001072 heteroaryl group Chemical group 0.000 claims description 6
- 125000006374 C2-C10 alkenyl group Chemical group 0.000 claims description 5
- 125000000217 alkyl group Chemical group 0.000 claims description 5
- 125000000753 cycloalkyl group Chemical group 0.000 claims description 5
- 125000004663 dialkyl amino group Chemical group 0.000 claims description 5
- 239000001257 hydrogen Substances 0.000 claims description 5
- 229910052739 hydrogen Inorganic materials 0.000 claims description 5
- 125000004642 (C1-C12) alkoxy group Chemical group 0.000 claims description 4
- 125000004453 alkoxycarbonyl group Chemical group 0.000 claims description 4
- 125000003282 alkyl amino group Chemical group 0.000 claims description 4
- 150000003863 ammonium salts Chemical class 0.000 claims description 4
- 150000001768 cations Chemical class 0.000 claims description 4
- SNOOUWRIMMFWNE-UHFFFAOYSA-M sodium;6-[(3,4,5-trimethoxybenzoyl)amino]hexanoate Chemical compound [Na+].COC1=CC(C(=O)NCCCCCC([O-])=O)=CC(OC)=C1OC SNOOUWRIMMFWNE-UHFFFAOYSA-M 0.000 claims description 4
- 239000003513 alkali Substances 0.000 claims description 3
- 238000000338 in vitro Methods 0.000 claims description 3
- 239000012454 non-polar solvent Substances 0.000 claims description 3
- 239000002798 polar solvent Substances 0.000 claims description 3
- 238000003860 storage Methods 0.000 claims description 3
- 238000006798 ring closing metathesis reaction Methods 0.000 claims description 2
- 125000004435 hydrogen atom Chemical class [H]* 0.000 claims 2
- 150000001639 boron compounds Chemical class 0.000 claims 1
- 230000008030 elimination Effects 0.000 claims 1
- 238000003379 elimination reaction Methods 0.000 claims 1
- 150000003254 radicals Chemical class 0.000 abstract description 12
- 229910052760 oxygen Inorganic materials 0.000 abstract description 8
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 abstract description 4
- 239000001301 oxygen Substances 0.000 abstract description 4
- 230000002292 Radical scavenging effect Effects 0.000 abstract 1
- 150000001723 carbon free-radicals Chemical class 0.000 abstract 1
- 210000003491 skin Anatomy 0.000 description 41
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 35
- ZAKOWWREFLAJOT-CEFNRUSXSA-N D-alpha-tocopherylacetate Chemical compound CC(=O)OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C ZAKOWWREFLAJOT-CEFNRUSXSA-N 0.000 description 20
- ZAKOWWREFLAJOT-UHFFFAOYSA-N d-alpha-Tocopheryl acetate Natural products CC(=O)OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C ZAKOWWREFLAJOT-UHFFFAOYSA-N 0.000 description 20
- FOYKKGHVWRFIBD-UHFFFAOYSA-N gamma-tocopherol acetate Natural products CC(=O)OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1 FOYKKGHVWRFIBD-UHFFFAOYSA-N 0.000 description 19
- GLDOVTGHNKAZLK-UHFFFAOYSA-N octadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCCCO GLDOVTGHNKAZLK-UHFFFAOYSA-N 0.000 description 17
- 239000002304 perfume Substances 0.000 description 17
- 235000006708 antioxidants Nutrition 0.000 description 15
- 229920000435 poly(dimethylsiloxane) Polymers 0.000 description 14
- 239000004205 dimethyl polysiloxane Substances 0.000 description 13
- 235000013870 dimethyl polysiloxane Nutrition 0.000 description 13
- 239000006210 lotion Substances 0.000 description 13
- 239000000344 soap Substances 0.000 description 13
- 239000006071 cream Substances 0.000 description 12
- 229940008099 dimethicone Drugs 0.000 description 12
- 229960004063 propylene glycol Drugs 0.000 description 12
- 239000000243 solution Substances 0.000 description 12
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 11
- 239000004359 castor oil Substances 0.000 description 11
- 235000019438 castor oil Nutrition 0.000 description 11
- ZEMPKEQAKRGZGQ-XOQCFJPHSA-N glycerol triricinoleate Natural products CCCCCC[C@@H](O)CC=CCCCCCCCC(=O)OC[C@@H](COC(=O)CCCCCCCC=CC[C@@H](O)CCCCCC)OC(=O)CCCCCCCC=CC[C@H](O)CCCCCC ZEMPKEQAKRGZGQ-XOQCFJPHSA-N 0.000 description 11
- 230000000694 effects Effects 0.000 description 8
- XJNUECKWDBNFJV-UHFFFAOYSA-N hexadecyl 2-ethylhexanoate Chemical compound CCCCCCCCCCCCCCCCOC(=O)C(CC)CCCC XJNUECKWDBNFJV-UHFFFAOYSA-N 0.000 description 8
- SNPLKNRPJHDVJA-ZETCQYMHSA-N D-panthenol Chemical compound OCC(C)(C)[C@@H](O)C(=O)NCCCO SNPLKNRPJHDVJA-ZETCQYMHSA-N 0.000 description 7
- 238000000034 method Methods 0.000 description 7
- GOQYKNQRPGWPLP-UHFFFAOYSA-N n-heptadecyl alcohol Natural products CCCCCCCCCCCCCCCCCO GOQYKNQRPGWPLP-UHFFFAOYSA-N 0.000 description 7
- 239000003921 oil Substances 0.000 description 7
- 235000019198 oils Nutrition 0.000 description 7
- 229940101267 panthenol Drugs 0.000 description 7
- 235000020957 pantothenol Nutrition 0.000 description 7
- 239000011619 pantothenol Substances 0.000 description 7
- 239000003755 preservative agent Substances 0.000 description 7
- 230000008569 process Effects 0.000 description 7
- 229940073639 ceteareth-6 Drugs 0.000 description 6
- 238000000354 decomposition reaction Methods 0.000 description 6
- 238000005259 measurement Methods 0.000 description 6
- OFBQJSOFQDEBGM-UHFFFAOYSA-N n-pentane Natural products CCCCC OFBQJSOFQDEBGM-UHFFFAOYSA-N 0.000 description 6
- CGIHFIDULQUVJG-UHFFFAOYSA-N phytantriol Chemical compound CC(C)CCCC(C)CCCC(C)CCCC(C)(O)C(O)CO CGIHFIDULQUVJG-UHFFFAOYSA-N 0.000 description 6
- CGIHFIDULQUVJG-VNTMZGSJSA-N phytantriol Natural products CC(C)CCC[C@H](C)CCC[C@H](C)CCC[C@@](C)(O)[C@H](O)CO CGIHFIDULQUVJG-VNTMZGSJSA-N 0.000 description 6
- 230000002335 preservative effect Effects 0.000 description 6
- 230000005855 radiation Effects 0.000 description 6
- 239000001993 wax Substances 0.000 description 6
- 125000000094 2-phenylethyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])C([H])([H])* 0.000 description 5
- 239000004480 active ingredient Substances 0.000 description 5
- 125000004432 carbon atom Chemical group C* 0.000 description 5
- 239000000499 gel Substances 0.000 description 5
- 239000002480 mineral oil Substances 0.000 description 5
- DXGLGDHPHMLXJC-UHFFFAOYSA-N oxybenzone Chemical compound OC1=CC(OC)=CC=C1C(=O)C1=CC=CC=C1 DXGLGDHPHMLXJC-UHFFFAOYSA-N 0.000 description 5
- 229960001173 oxybenzone Drugs 0.000 description 5
- 229920006395 saturated elastomer Polymers 0.000 description 5
- CIHOLLKRGTVIJN-UHFFFAOYSA-N tert‐butyl hydroperoxide Chemical compound CC(C)(C)OO CIHOLLKRGTVIJN-UHFFFAOYSA-N 0.000 description 5
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical group N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 4
- 206010013786 Dry skin Diseases 0.000 description 4
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 4
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 4
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical compound [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 description 4
- GWEVSGVZZGPLCZ-UHFFFAOYSA-N Titan oxide Chemical compound O=[Ti]=O GWEVSGVZZGPLCZ-UHFFFAOYSA-N 0.000 description 4
- 230000032683 aging Effects 0.000 description 4
- POJWUDADGALRAB-UHFFFAOYSA-N allantoin Chemical compound NC(=O)NC1NC(=O)NC1=O POJWUDADGALRAB-UHFFFAOYSA-N 0.000 description 4
- XUJNEKJLAYXESH-UHFFFAOYSA-N cysteine Natural products SCC(N)C(O)=O XUJNEKJLAYXESH-UHFFFAOYSA-N 0.000 description 4
- 235000018417 cysteine Nutrition 0.000 description 4
- 150000002148 esters Chemical class 0.000 description 4
- 239000006260 foam Substances 0.000 description 4
- 229940119170 jojoba wax Drugs 0.000 description 4
- HQKMJHAJHXVSDF-UHFFFAOYSA-L magnesium stearate Chemical compound [Mg+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O HQKMJHAJHXVSDF-UHFFFAOYSA-L 0.000 description 4
- 235000010446 mineral oil Nutrition 0.000 description 4
- WWZKQHOCKIZLMA-UHFFFAOYSA-N octanoic acid Chemical compound CCCCCCCC(O)=O WWZKQHOCKIZLMA-UHFFFAOYSA-N 0.000 description 4
- 230000001590 oxidative effect Effects 0.000 description 4
- 230000004224 protection Effects 0.000 description 4
- YRWWOAFMPXPHEJ-OFBPEYICSA-K sodium L-ascorbic acid 2-phosphate Chemical compound [Na+].[Na+].[Na+].OC[C@H](O)[C@H]1OC(=O)C(OP([O-])([O-])=O)=C1[O-] YRWWOAFMPXPHEJ-OFBPEYICSA-K 0.000 description 4
- 229940048058 sodium ascorbyl phosphate Drugs 0.000 description 4
- 239000007921 spray Substances 0.000 description 4
- 239000000126 substance Substances 0.000 description 4
- 239000011593 sulfur Substances 0.000 description 4
- 229910052717 sulfur Inorganic materials 0.000 description 4
- 238000011282 treatment Methods 0.000 description 4
- 150000003626 triacylglycerols Chemical class 0.000 description 4
- WTVHAMTYZJGJLJ-UHFFFAOYSA-N (+)-(4S,8R)-8-epi-beta-bisabolol Natural products CC(C)=CCCC(C)C1(O)CCC(C)=CC1 WTVHAMTYZJGJLJ-UHFFFAOYSA-N 0.000 description 3
- RGZSQWQPBWRIAQ-CABCVRRESA-N (-)-alpha-Bisabolol Chemical compound CC(C)=CCC[C@](C)(O)[C@H]1CCC(C)=CC1 RGZSQWQPBWRIAQ-CABCVRRESA-N 0.000 description 3
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 3
- 235000019489 Almond oil Nutrition 0.000 description 3
- LEVWYRKDKASIDU-QWWZWVQMSA-N D-cystine Chemical compound OC(=O)[C@H](N)CSSC[C@@H](N)C(O)=O LEVWYRKDKASIDU-QWWZWVQMSA-N 0.000 description 3
- XUJNEKJLAYXESH-REOHCLBHSA-N L-Cysteine Chemical compound SC[C@H](N)C(O)=O XUJNEKJLAYXESH-REOHCLBHSA-N 0.000 description 3
- 235000018330 Macadamia integrifolia Nutrition 0.000 description 3
- 240000000912 Macadamia tetraphylla Species 0.000 description 3
- 235000003800 Macadamia tetraphylla Nutrition 0.000 description 3
- 108010000684 Matrix Metalloproteinases Proteins 0.000 description 3
- 102000002274 Matrix Metalloproteinases Human genes 0.000 description 3
- 238000005481 NMR spectroscopy Methods 0.000 description 3
- YBGZDTIWKVFICR-JLHYYAGUSA-N Octyl 4-methoxycinnamic acid Chemical compound CCCCC(CC)COC(=O)\C=C\C1=CC=C(OC)C=C1 YBGZDTIWKVFICR-JLHYYAGUSA-N 0.000 description 3
- CBENFWSGALASAD-UHFFFAOYSA-N Ozone Chemical compound [O-][O+]=O CBENFWSGALASAD-UHFFFAOYSA-N 0.000 description 3
- 235000004789 Rosa xanthina Nutrition 0.000 description 3
- 241000220222 Rosaceae Species 0.000 description 3
- 206010040954 Skin wrinkling Diseases 0.000 description 3
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 description 3
- 206010000496 acne Diseases 0.000 description 3
- 239000008168 almond oil Substances 0.000 description 3
- RGZSQWQPBWRIAQ-LSDHHAIUSA-N alpha-Bisabolol Natural products CC(C)=CCC[C@@](C)(O)[C@@H]1CCC(C)=CC1 RGZSQWQPBWRIAQ-LSDHHAIUSA-N 0.000 description 3
- 230000003110 anti-inflammatory effect Effects 0.000 description 3
- 208000010668 atopic eczema Diseases 0.000 description 3
- 229940036350 bisabolol Drugs 0.000 description 3
- HHGZABIIYIWLGA-UHFFFAOYSA-N bisabolol Natural products CC1CCC(C(C)(O)CCC=C(C)C)CC1 HHGZABIIYIWLGA-UHFFFAOYSA-N 0.000 description 3
- 239000001273 butane Substances 0.000 description 3
- 229910052799 carbon Inorganic materials 0.000 description 3
- 210000004027 cell Anatomy 0.000 description 3
- 229940081733 cetearyl alcohol Drugs 0.000 description 3
- 125000004122 cyclic group Chemical group 0.000 description 3
- 229960003067 cystine Drugs 0.000 description 3
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 3
- 208000035475 disorder Diseases 0.000 description 3
- 230000037336 dry skin Effects 0.000 description 3
- 239000003995 emulsifying agent Substances 0.000 description 3
- 238000009472 formulation Methods 0.000 description 3
- 125000000959 isobutyl group Chemical group [H]C([H])([H])C([H])(C([H])([H])[H])C([H])([H])* 0.000 description 3
- 125000001972 isopentyl group Chemical group [H]C([H])([H])C([H])(C([H])([H])[H])C([H])([H])C([H])([H])* 0.000 description 3
- 125000001449 isopropyl group Chemical group [H]C([H])([H])C([H])(*)C([H])([H])[H] 0.000 description 3
- XUGNVMKQXJXZCD-UHFFFAOYSA-N isopropyl palmitate Chemical compound CCCCCCCCCCCCCCCC(=O)OC(C)C XUGNVMKQXJXZCD-UHFFFAOYSA-N 0.000 description 3
- 229940075495 isopropyl palmitate Drugs 0.000 description 3
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 3
- 230000003020 moisturizing effect Effects 0.000 description 3
- IJDNQMDRQITEOD-UHFFFAOYSA-N n-butane Chemical compound CCCC IJDNQMDRQITEOD-UHFFFAOYSA-N 0.000 description 3
- 125000004108 n-butyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 3
- 125000000740 n-pentyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 3
- 125000004123 n-propyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])* 0.000 description 3
- 125000001971 neopentyl group Chemical group [H]C([*])([H])C(C([H])([H])[H])(C([H])([H])[H])C([H])([H])[H] 0.000 description 3
- 150000002830 nitrogen compounds Chemical class 0.000 description 3
- 239000010466 nut oil Substances 0.000 description 3
- 229960001679 octinoxate Drugs 0.000 description 3
- 229940086539 peg-7 glyceryl cocoate Drugs 0.000 description 3
- 239000000049 pigment Substances 0.000 description 3
- 125000002914 sec-butyl group Chemical group [H]C([H])([H])C([H])([H])C([H])(*)C([H])([H])[H] 0.000 description 3
- 208000017520 skin disease Diseases 0.000 description 3
- 238000001228 spectrum Methods 0.000 description 3
- 239000004408 titanium dioxide Substances 0.000 description 3
- 229930003799 tocopherol Natural products 0.000 description 3
- 239000011732 tocopherol Substances 0.000 description 3
- 150000003722 vitamin derivatives Chemical class 0.000 description 3
- JNYAEWCLZODPBN-JGWLITMVSA-N (2r,3r,4s)-2-[(1r)-1,2-dihydroxyethyl]oxolane-3,4-diol Chemical class OC[C@@H](O)[C@H]1OC[C@H](O)[C@H]1O JNYAEWCLZODPBN-JGWLITMVSA-N 0.000 description 2
- 125000004493 2-methylbut-1-yl group Chemical group CC(C*)CC 0.000 description 2
- HIQIXEFWDLTDED-UHFFFAOYSA-N 4-hydroxy-1-piperidin-4-ylpyrrolidin-2-one Chemical compound O=C1CC(O)CN1C1CCNCC1 HIQIXEFWDLTDED-UHFFFAOYSA-N 0.000 description 2
- 208000002874 Acne Vulgaris Diseases 0.000 description 2
- POJWUDADGALRAB-PVQJCKRUSA-N Allantoin Natural products NC(=O)N[C@@H]1NC(=O)NC1=O POJWUDADGALRAB-PVQJCKRUSA-N 0.000 description 2
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 2
- WKBOTKDWSSQWDR-UHFFFAOYSA-N Bromine atom Chemical compound [Br] WKBOTKDWSSQWDR-UHFFFAOYSA-N 0.000 description 2
- ZAMOUSCENKQFHK-UHFFFAOYSA-N Chlorine atom Chemical compound [Cl] ZAMOUSCENKQFHK-UHFFFAOYSA-N 0.000 description 2
- XMSXQFUHVRWGNA-UHFFFAOYSA-N Decamethylcyclopentasiloxane Chemical compound C[Si]1(C)O[Si](C)(C)O[Si](C)(C)O[Si](C)(C)O[Si](C)(C)O1 XMSXQFUHVRWGNA-UHFFFAOYSA-N 0.000 description 2
- 206010012438 Dermatitis atopic Diseases 0.000 description 2
- MYMOFIZGZYHOMD-UHFFFAOYSA-N Dioxygen Chemical compound O=O MYMOFIZGZYHOMD-UHFFFAOYSA-N 0.000 description 2
- KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 2
- 102000004190 Enzymes Human genes 0.000 description 2
- 108090000790 Enzymes Proteins 0.000 description 2
- PXGOKWXKJXAPGV-UHFFFAOYSA-N Fluorine Chemical compound FF PXGOKWXKJXAPGV-UHFFFAOYSA-N 0.000 description 2
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 2
- 208000001126 Keratosis Diseases 0.000 description 2
- 239000004166 Lanolin Substances 0.000 description 2
- 206010051246 Photodermatosis Diseases 0.000 description 2
- 239000004698 Polyethylene Substances 0.000 description 2
- ATUOYWHBWRKTHZ-UHFFFAOYSA-N Propane Chemical compound CCC ATUOYWHBWRKTHZ-UHFFFAOYSA-N 0.000 description 2
- VYGQUTWHTHXGQB-FFHKNEKCSA-N Retinol Palmitate Chemical compound CCCCCCCCCCCCCCCC(=O)OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C VYGQUTWHTHXGQB-FFHKNEKCSA-N 0.000 description 2
- 206010039792 Seborrhoea Diseases 0.000 description 2
- 206010039793 Seborrhoeic dermatitis Diseases 0.000 description 2
- 229920002125 Sokalan® Polymers 0.000 description 2
- 206010041303 Solar dermatitis Diseases 0.000 description 2
- DKGAVHZHDRPRBM-UHFFFAOYSA-N Tert-Butanol Chemical compound CC(C)(C)O DKGAVHZHDRPRBM-UHFFFAOYSA-N 0.000 description 2
- UJNOLBSYLSYIBM-WISYIIOYSA-N [(1r,2s,5r)-5-methyl-2-propan-2-ylcyclohexyl] (2r)-2-hydroxypropanoate Chemical compound CC(C)[C@@H]1CC[C@@H](C)C[C@H]1OC(=O)[C@@H](C)O UJNOLBSYLSYIBM-WISYIIOYSA-N 0.000 description 2
- QTBSBXVTEAMEQO-GUEYOVJQSA-N acetic acid-d4 Chemical compound [2H]OC(=O)C([2H])([2H])[2H] QTBSBXVTEAMEQO-GUEYOVJQSA-N 0.000 description 2
- 239000013543 active substance Substances 0.000 description 2
- 239000000443 aerosol Substances 0.000 description 2
- ANVAOWXLWRTKGA-XHGAXZNDSA-N all-trans-alpha-carotene Chemical compound CC=1CCCC(C)(C)C=1/C=C/C(/C)=C/C=C/C(/C)=C/C=C/C=C(C)C=CC=C(C)C=CC1C(C)=CCCC1(C)C ANVAOWXLWRTKGA-XHGAXZNDSA-N 0.000 description 2
- 229960000458 allantoin Drugs 0.000 description 2
- 230000000172 allergic effect Effects 0.000 description 2
- 235000013871 bee wax Nutrition 0.000 description 2
- 239000012166 beeswax Substances 0.000 description 2
- 238000004061 bleaching Methods 0.000 description 2
- GDTBXPJZTBHREO-UHFFFAOYSA-N bromine Substances BrBr GDTBXPJZTBHREO-UHFFFAOYSA-N 0.000 description 2
- 229910052794 bromium Inorganic materials 0.000 description 2
- 239000001913 cellulose Substances 0.000 description 2
- 229920002678 cellulose Polymers 0.000 description 2
- 239000000460 chlorine Substances 0.000 description 2
- 229910052801 chlorine Inorganic materials 0.000 description 2
- 235000019504 cigarettes Nutrition 0.000 description 2
- 238000004140 cleaning Methods 0.000 description 2
- 229920001577 copolymer Polymers 0.000 description 2
- 125000000113 cyclohexyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])(*)C([H])([H])C1([H])[H] 0.000 description 2
- 229940086555 cyclomethicone Drugs 0.000 description 2
- 125000001511 cyclopentyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])(*)C1([H])[H] 0.000 description 2
- 125000001559 cyclopropyl group Chemical group [H]C1([H])C([H])([H])C1([H])* 0.000 description 2
- GVJHHUAWPYXKBD-UHFFFAOYSA-N d-alpha-tocopherol Natural products OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 2
- 230000006378 damage Effects 0.000 description 2
- 239000002781 deodorant agent Substances 0.000 description 2
- 239000000839 emulsion Substances 0.000 description 2
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 2
- 235000008524 evening primrose extract Nutrition 0.000 description 2
- 229940089020 evening primrose oil Drugs 0.000 description 2
- 239000010475 evening primrose oil Substances 0.000 description 2
- 230000001815 facial effect Effects 0.000 description 2
- 239000003925 fat Substances 0.000 description 2
- 239000012530 fluid Substances 0.000 description 2
- 239000011737 fluorine Substances 0.000 description 2
- 229910052731 fluorine Inorganic materials 0.000 description 2
- 235000011187 glycerol Nutrition 0.000 description 2
- 229910052736 halogen Inorganic materials 0.000 description 2
- 150000002367 halogens Chemical class 0.000 description 2
- 125000005842 heteroatom Chemical group 0.000 description 2
- 238000000990 heteronuclear single quantum coherence spectrum Methods 0.000 description 2
- 150000002431 hydrogen Chemical class 0.000 description 2
- 229940049290 hydrogenated coco-glycerides Drugs 0.000 description 2
- 125000004356 hydroxy functional group Chemical group O* 0.000 description 2
- 230000002757 inflammatory effect Effects 0.000 description 2
- 239000004615 ingredient Substances 0.000 description 2
- 239000003112 inhibitor Substances 0.000 description 2
- 229910052500 inorganic mineral Inorganic materials 0.000 description 2
- NNPPMTNAJDCUHE-UHFFFAOYSA-N isobutane Chemical compound CC(C)C NNPPMTNAJDCUHE-UHFFFAOYSA-N 0.000 description 2
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 2
- 235000019388 lanolin Nutrition 0.000 description 2
- 229940039717 lanolin Drugs 0.000 description 2
- 230000003859 lipid peroxidation Effects 0.000 description 2
- 239000007788 liquid Substances 0.000 description 2
- 235000019359 magnesium stearate Nutrition 0.000 description 2
- 230000007246 mechanism Effects 0.000 description 2
- 229910052751 metal Inorganic materials 0.000 description 2
- 239000002184 metal Substances 0.000 description 2
- 239000011707 mineral Substances 0.000 description 2
- 235000010755 mineral Nutrition 0.000 description 2
- 125000001624 naphthyl group Chemical group 0.000 description 2
- 239000002353 niosome Substances 0.000 description 2
- 229910052757 nitrogen Inorganic materials 0.000 description 2
- 229910017464 nitrogen compound Inorganic materials 0.000 description 2
- 230000037312 oily skin Effects 0.000 description 2
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 description 2
- 229920000573 polyethylene Polymers 0.000 description 2
- 229920005862 polyol Polymers 0.000 description 2
- 150000003077 polyols Chemical class 0.000 description 2
- 239000000843 powder Substances 0.000 description 2
- 239000003380 propellant Substances 0.000 description 2
- 230000009979 protective mechanism Effects 0.000 description 2
- NPCOQXAVBJJZBQ-UHFFFAOYSA-N reduced coenzyme Q9 Natural products COC1=C(O)C(C)=C(CC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)C)C(O)=C1OC NPCOQXAVBJJZBQ-UHFFFAOYSA-N 0.000 description 2
- 230000009467 reduction Effects 0.000 description 2
- 125000003548 sec-pentyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])(*)C([H])([H])[H] 0.000 description 2
- 239000000377 silicon dioxide Substances 0.000 description 2
- 230000009759 skin aging Effects 0.000 description 2
- 239000000779 smoke Substances 0.000 description 2
- 239000002904 solvent Substances 0.000 description 2
- 125000000999 tert-butyl group Chemical group [H]C([H])([H])C(*)(C([H])([H])[H])C([H])([H])[H] 0.000 description 2
- 125000001973 tert-pentyl group Chemical group [H]C([H])([H])C([H])([H])C(*)(C([H])([H])[H])C([H])([H])[H] 0.000 description 2
- 239000002562 thickening agent Substances 0.000 description 2
- 235000010384 tocopherol Nutrition 0.000 description 2
- 229960001295 tocopherol Drugs 0.000 description 2
- 239000003053 toxin Substances 0.000 description 2
- 231100000765 toxin Toxicity 0.000 description 2
- 108700012359 toxins Proteins 0.000 description 2
- 229930003231 vitamin Natural products 0.000 description 2
- 235000013343 vitamin Nutrition 0.000 description 2
- 239000011782 vitamin Substances 0.000 description 2
- 229940088594 vitamin Drugs 0.000 description 2
- 238000005406 washing Methods 0.000 description 2
- 230000037303 wrinkles Effects 0.000 description 2
- GVJHHUAWPYXKBD-IEOSBIPESA-N α-tocopherol Chemical compound OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-IEOSBIPESA-N 0.000 description 2
- CRDAMVZIKSXKFV-FBXUGWQNSA-N (2-cis,6-cis)-farnesol Chemical compound CC(C)=CCC\C(C)=C/CC\C(C)=C/CO CRDAMVZIKSXKFV-FBXUGWQNSA-N 0.000 description 1
- 239000000260 (2E,6E)-3,7,11-trimethyldodeca-2,6,10-trien-1-ol Substances 0.000 description 1
- DBSABEYSGXPBTA-RXSVEWSESA-N (2r)-2-[(1s)-1,2-dihydroxyethyl]-3,4-dihydroxy-2h-furan-5-one;phosphoric acid Chemical compound OP(O)(O)=O.OC[C@H](O)[C@H]1OC(=O)C(O)=C1O DBSABEYSGXPBTA-RXSVEWSESA-N 0.000 description 1
- IZFHEQBZOYJLPK-SSDOTTSWSA-N (R)-dihydrolipoic acid Chemical compound OC(=O)CCCC[C@@H](S)CCS IZFHEQBZOYJLPK-SSDOTTSWSA-N 0.000 description 1
- 125000005919 1,2,2-trimethylpropyl group Chemical group 0.000 description 1
- 125000005918 1,2-dimethylbutyl group Chemical group 0.000 description 1
- DWANEFRJKWXRSG-UHFFFAOYSA-N 1,2-tetradecanediol Chemical compound CCCCCCCCCCCCC(O)CO DWANEFRJKWXRSG-UHFFFAOYSA-N 0.000 description 1
- OWEGWHBOCFMBLP-UHFFFAOYSA-N 1-(4-chlorophenoxy)-1-(1H-imidazol-1-yl)-3,3-dimethylbutan-2-one Chemical compound C1=CN=CN1C(C(=O)C(C)(C)C)OC1=CC=C(Cl)C=C1 OWEGWHBOCFMBLP-UHFFFAOYSA-N 0.000 description 1
- 125000004973 1-butenyl group Chemical group C(=CCC)* 0.000 description 1
- 125000006433 1-ethyl cyclopropyl group Chemical group [H]C([H])([H])C([H])([H])C1(*)C([H])([H])C1([H])[H] 0.000 description 1
- 125000006218 1-ethylbutyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])(*)C([H])([H])C([H])([H])[H] 0.000 description 1
- 125000006039 1-hexenyl group Chemical group 0.000 description 1
- 125000006432 1-methyl cyclopropyl group Chemical group [H]C([H])([H])C1(*)C([H])([H])C1([H])[H] 0.000 description 1
- VBICKXHEKHSIBG-UHFFFAOYSA-N 1-monostearoylglycerol Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCC(O)CO VBICKXHEKHSIBG-UHFFFAOYSA-N 0.000 description 1
- IIZPXYDJLKNOIY-JXPKJXOSSA-N 1-palmitoyl-2-arachidonoyl-sn-glycero-3-phosphocholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCC\C=C/C\C=C/C\C=C/C\C=C/CCCCC IIZPXYDJLKNOIY-JXPKJXOSSA-N 0.000 description 1
- 125000006023 1-pentenyl group Chemical group 0.000 description 1
- FPIPGXGPPPQFEQ-UHFFFAOYSA-N 13-cis retinol Natural products OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-UHFFFAOYSA-N 0.000 description 1
- FLPJVCMIKUWSDR-UHFFFAOYSA-N 2-(4-formylphenoxy)acetamide Chemical compound NC(=O)COC1=CC=C(C=O)C=C1 FLPJVCMIKUWSDR-UHFFFAOYSA-N 0.000 description 1
- 125000004974 2-butenyl group Chemical group C(C=CC)* 0.000 description 1
- ZNQVEEAIQZEUHB-UHFFFAOYSA-N 2-ethoxyethanol Chemical compound CCOCCO ZNQVEEAIQZEUHB-UHFFFAOYSA-N 0.000 description 1
- 125000006176 2-ethylbutyl group Chemical group [H]C([H])([H])C([H])([H])C([H])(C([H])([H])*)C([H])([H])C([H])([H])[H] 0.000 description 1
- 125000006040 2-hexenyl group Chemical group 0.000 description 1
- MWKPHOIHTLQZIY-UHFFFAOYSA-N 2-hexyldecyl octadecanoate Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCC(CCCCCC)CCCCCCCC MWKPHOIHTLQZIY-UHFFFAOYSA-N 0.000 description 1
- 125000006026 2-methyl-1-butenyl group Chemical group 0.000 description 1
- 125000006029 2-methyl-2-butenyl group Chemical group 0.000 description 1
- 125000005916 2-methylpentyl group Chemical group 0.000 description 1
- LEACJMVNYZDSKR-UHFFFAOYSA-N 2-octyldodecan-1-ol Chemical compound CCCCCCCCCCC(CO)CCCCCCCC LEACJMVNYZDSKR-UHFFFAOYSA-N 0.000 description 1
- 125000006024 2-pentenyl group Chemical group 0.000 description 1
- CWVRJTMFETXNAD-FWCWNIRPSA-N 3-O-Caffeoylquinic acid Natural products O[C@H]1[C@@H](O)C[C@@](O)(C(O)=O)C[C@H]1OC(=O)\C=C\C1=CC=C(O)C(O)=C1 CWVRJTMFETXNAD-FWCWNIRPSA-N 0.000 description 1
- 125000006027 3-methyl-1-butenyl group Chemical group 0.000 description 1
- 125000003542 3-methylbutan-2-yl group Chemical group [H]C([H])([H])C([H])(*)C([H])(C([H])([H])[H])C([H])([H])[H] 0.000 description 1
- 125000005917 3-methylpentyl group Chemical group 0.000 description 1
- 244000215068 Acacia senegal Species 0.000 description 1
- NIXOWILDQLNWCW-UHFFFAOYSA-N Acrylic acid Chemical compound OC(=O)C=C NIXOWILDQLNWCW-UHFFFAOYSA-N 0.000 description 1
- 239000004910 After sun product Substances 0.000 description 1
- 201000004384 Alopecia Diseases 0.000 description 1
- 241000195940 Bryophyta Species 0.000 description 1
- 239000004255 Butylated hydroxyanisole Substances 0.000 description 1
- 239000004322 Butylated hydroxytoluene Substances 0.000 description 1
- NLZUEZXRPGMBCV-UHFFFAOYSA-N Butylhydroxytoluene Chemical compound CC1=CC(C(C)(C)C)=C(O)C(C(C)(C)C)=C1 NLZUEZXRPGMBCV-UHFFFAOYSA-N 0.000 description 1
- GAWIXWVDTYZWAW-UHFFFAOYSA-N C[CH]O Chemical group C[CH]O GAWIXWVDTYZWAW-UHFFFAOYSA-N 0.000 description 1
- PZIRUHCJZBGLDY-UHFFFAOYSA-N Caffeoylquinic acid Natural products CC(CCC(=O)C(C)C1C(=O)CC2C3CC(O)C4CC(O)CCC4(C)C3CCC12C)C(=O)O PZIRUHCJZBGLDY-UHFFFAOYSA-N 0.000 description 1
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 1
- 229920002134 Carboxymethyl cellulose Polymers 0.000 description 1
- 102000016938 Catalase Human genes 0.000 description 1
- 108010053835 Catalase Proteins 0.000 description 1
- 208000035484 Cellulite Diseases 0.000 description 1
- ACTIUHUUMQJHFO-UHFFFAOYSA-N Coenzym Q10 Natural products COC1=C(OC)C(=O)C(CC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)C)=C(C)C1=O ACTIUHUUMQJHFO-UHFFFAOYSA-N 0.000 description 1
- 102000008186 Collagen Human genes 0.000 description 1
- 108010035532 Collagen Proteins 0.000 description 1
- 108060005980 Collagenase Proteins 0.000 description 1
- 102000029816 Collagenase Human genes 0.000 description 1
- 229920000858 Cyclodextrin Polymers 0.000 description 1
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 1
- 206010011953 Decreased activity Diseases 0.000 description 1
- 206010048768 Dermatosis Diseases 0.000 description 1
- 108010016626 Dipeptides Proteins 0.000 description 1
- SNRUBQQJIBEYMU-UHFFFAOYSA-N Dodecane Natural products CCCCCCCCCCCC SNRUBQQJIBEYMU-UHFFFAOYSA-N 0.000 description 1
- 102000016942 Elastin Human genes 0.000 description 1
- 108010014258 Elastin Proteins 0.000 description 1
- 102000010834 Extracellular Matrix Proteins Human genes 0.000 description 1
- 108010037362 Extracellular Matrix Proteins Proteins 0.000 description 1
- 108010010803 Gelatin Proteins 0.000 description 1
- 108010026132 Gelatinases Proteins 0.000 description 1
- 102000013382 Gelatinases Human genes 0.000 description 1
- 229920002683 Glycosaminoglycan Polymers 0.000 description 1
- 229920000084 Gum arabic Polymers 0.000 description 1
- 241000208680 Hamamelis mollis Species 0.000 description 1
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 description 1
- 239000004354 Hydroxyethyl cellulose Substances 0.000 description 1
- 229920000663 Hydroxyethyl cellulose Polymers 0.000 description 1
- 206010020649 Hyperkeratosis Diseases 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- 102000015696 Interleukins Human genes 0.000 description 1
- 108010063738 Interleukins Proteins 0.000 description 1
- 239000011786 L-ascorbyl-6-palmitate Substances 0.000 description 1
- QAQJMLQRFWZOBN-LAUBAEHRSA-N L-ascorbyl-6-palmitate Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](O)[C@H]1OC(=O)C(O)=C1O QAQJMLQRFWZOBN-LAUBAEHRSA-N 0.000 description 1
- 229920000161 Locust bean gum Polymers 0.000 description 1
- UPYKUZBSLRQECL-UKMVMLAPSA-N Lycopene Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1C(=C)CCCC1(C)C)C=CC=C(/C)C=CC2C(=C)CCCC2(C)C UPYKUZBSLRQECL-UKMVMLAPSA-N 0.000 description 1
- JEVVKJMRZMXFBT-XWDZUXABSA-N Lycophyll Natural products OC/C(=C/CC/C(=C\C=C\C(=C/C=C/C(=C\C=C\C=C(/C=C/C=C(\C=C\C=C(/CC/C=C(/CO)\C)\C)/C)\C)/C)\C)/C)/C JEVVKJMRZMXFBT-XWDZUXABSA-N 0.000 description 1
- CSNNHWWHGAXBCP-UHFFFAOYSA-L Magnesium sulfate Chemical class [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- CWVRJTMFETXNAD-KLZCAUPSSA-N Neochlorogenin-saeure Natural products O[C@H]1C[C@@](O)(C[C@@H](OC(=O)C=Cc2ccc(O)c(O)c2)[C@@H]1O)C(=O)O CWVRJTMFETXNAD-KLZCAUPSSA-N 0.000 description 1
- 229910019142 PO4 Inorganic materials 0.000 description 1
- 235000019482 Palm oil Nutrition 0.000 description 1
- 206010049752 Peau d'orange Diseases 0.000 description 1
- 239000004264 Petrolatum Substances 0.000 description 1
- IMQLKJBTEOYOSI-UHFFFAOYSA-N Phytic acid Natural products OP(O)(=O)OC1C(OP(O)(O)=O)C(OP(O)(O)=O)C(OP(O)(O)=O)C(OP(O)(O)=O)C1OP(O)(O)=O IMQLKJBTEOYOSI-UHFFFAOYSA-N 0.000 description 1
- 229920000688 Poly[(2-ethyldimethylammonioethyl methacrylate ethyl sulfate)-co-(1-vinylpyrrolidone)] Polymers 0.000 description 1
- 239000004952 Polyamide Substances 0.000 description 1
- 239000004372 Polyvinyl alcohol Substances 0.000 description 1
- 208000003251 Pruritus Diseases 0.000 description 1
- VYGQUTWHTHXGQB-UHFFFAOYSA-N Retinol hexadecanoate Natural products CCCCCCCCCCCCCCCC(=O)OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C VYGQUTWHTHXGQB-UHFFFAOYSA-N 0.000 description 1
- 235000003846 Ricinus Nutrition 0.000 description 1
- 241000322381 Ricinus <louse> Species 0.000 description 1
- 206010043189 Telangiectasia Diseases 0.000 description 1
- GSEJCLTVZPLZKY-UHFFFAOYSA-N Triethanolamine Chemical compound OCCN(CCO)CCO GSEJCLTVZPLZKY-UHFFFAOYSA-N 0.000 description 1
- FPIPGXGPPPQFEQ-BOOMUCAASA-N Vitamin A Natural products OC/C=C(/C)\C=C\C=C(\C)/C=C/C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-BOOMUCAASA-N 0.000 description 1
- 229930003268 Vitamin C Natural products 0.000 description 1
- 235000010489 acacia gum Nutrition 0.000 description 1
- 239000000205 acacia gum Substances 0.000 description 1
- 229920006322 acrylamide copolymer Polymers 0.000 description 1
- 150000001252 acrylic acid derivatives Chemical class 0.000 description 1
- 230000004913 activation Effects 0.000 description 1
- 239000000654 additive Substances 0.000 description 1
- 235000010443 alginic acid Nutrition 0.000 description 1
- 229920000615 alginic acid Polymers 0.000 description 1
- 150000001342 alkaline earth metals Chemical class 0.000 description 1
- 125000005210 alkyl ammonium group Chemical group 0.000 description 1
- OENHQHLEOONYIE-UKMVMLAPSA-N all-trans beta-carotene Natural products CC=1CCCC(C)(C)C=1/C=C/C(/C)=C/C=C/C(/C)=C/C=C/C=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C OENHQHLEOONYIE-UKMVMLAPSA-N 0.000 description 1
- FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 description 1
- 231100000360 alopecia Toxicity 0.000 description 1
- 150000001280 alpha hydroxy acids Chemical class 0.000 description 1
- 239000011795 alpha-carotene Substances 0.000 description 1
- 235000003903 alpha-carotene Nutrition 0.000 description 1
- ANVAOWXLWRTKGA-HLLMEWEMSA-N alpha-carotene Natural products C(=C\C=C\C=C(/C=C/C=C(\C=C\C=1C(C)(C)CCCC=1C)/C)\C)(\C=C\C=C(/C=C/[C@H]1C(C)=CCCC1(C)C)\C)/C ANVAOWXLWRTKGA-HLLMEWEMSA-N 0.000 description 1
- CEGOLXSVJUTHNZ-UHFFFAOYSA-K aluminium tristearate Chemical compound [Al+3].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O CEGOLXSVJUTHNZ-UHFFFAOYSA-K 0.000 description 1
- 229940063655 aluminum stearate Drugs 0.000 description 1
- CBTVGIZVANVGBH-UHFFFAOYSA-N aminomethyl propanol Chemical compound CC(C)(N)CO CBTVGIZVANVGBH-UHFFFAOYSA-N 0.000 description 1
- QGZKDVFQNNGYKY-UHFFFAOYSA-O ammonium group Chemical group [NH4+] QGZKDVFQNNGYKY-UHFFFAOYSA-O 0.000 description 1
- 235000021120 animal protein Nutrition 0.000 description 1
- 239000000058 anti acne agent Substances 0.000 description 1
- 230000003266 anti-allergic effect Effects 0.000 description 1
- 230000000844 anti-bacterial effect Effects 0.000 description 1
- 230000000845 anti-microbial effect Effects 0.000 description 1
- 230000001166 anti-perspirative effect Effects 0.000 description 1
- 230000001153 anti-wrinkle effect Effects 0.000 description 1
- 229940124340 antiacne agent Drugs 0.000 description 1
- 239000002518 antifoaming agent Substances 0.000 description 1
- 239000004599 antimicrobial Substances 0.000 description 1
- 239000003213 antiperspirant Substances 0.000 description 1
- 239000008346 aqueous phase Substances 0.000 description 1
- BTFJIXJJCSYFAL-UHFFFAOYSA-N arachidyl alcohol Natural products CCCCCCCCCCCCCCCCCCCCO BTFJIXJJCSYFAL-UHFFFAOYSA-N 0.000 description 1
- 235000010385 ascorbyl palmitate Nutrition 0.000 description 1
- 229940071097 ascorbyl phosphate Drugs 0.000 description 1
- 201000008937 atopic dermatitis Diseases 0.000 description 1
- 230000001363 autoimmune Effects 0.000 description 1
- 235000021302 avocado oil Nutrition 0.000 description 1
- 239000008163 avocado oil Substances 0.000 description 1
- 239000003899 bactericide agent Substances 0.000 description 1
- 230000004888 barrier function Effects 0.000 description 1
- 238000003287 bathing Methods 0.000 description 1
- 239000000440 bentonite Substances 0.000 description 1
- 229910000278 bentonite Inorganic materials 0.000 description 1
- SVPXDRXYRYOSEX-UHFFFAOYSA-N bentoquatam Chemical compound O.O=[Si]=O.O=[Al]O[Al]=O SVPXDRXYRYOSEX-UHFFFAOYSA-N 0.000 description 1
- 150000001277 beta hydroxy acids Chemical class 0.000 description 1
- 235000013734 beta-carotene Nutrition 0.000 description 1
- 239000011648 beta-carotene Substances 0.000 description 1
- TUPZEYHYWIEDIH-WAIFQNFQSA-N beta-carotene Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CCCC1(C)C)C=CC=C(/C)C=CC2=CCCCC2(C)C TUPZEYHYWIEDIH-WAIFQNFQSA-N 0.000 description 1
- 229960002747 betacarotene Drugs 0.000 description 1
- 210000004204 blood vessel Anatomy 0.000 description 1
- 229910021538 borax Inorganic materials 0.000 description 1
- 235000019282 butylated hydroxyanisole Nutrition 0.000 description 1
- CZBZUDVBLSSABA-UHFFFAOYSA-N butylated hydroxyanisole Chemical compound COC1=CC=C(O)C(C(C)(C)C)=C1.COC1=CC=C(O)C=C1C(C)(C)C CZBZUDVBLSSABA-UHFFFAOYSA-N 0.000 description 1
- 229940043253 butylated hydroxyanisole Drugs 0.000 description 1
- 235000010354 butylated hydroxytoluene Nutrition 0.000 description 1
- 229940095259 butylated hydroxytoluene Drugs 0.000 description 1
- 229960001631 carbomer Drugs 0.000 description 1
- 239000001768 carboxy methyl cellulose Substances 0.000 description 1
- 235000010948 carboxy methyl cellulose Nutrition 0.000 description 1
- MRUAUOIMASANKQ-UHFFFAOYSA-O carboxymethyl-[3-(dodecanoylamino)propyl]-dimethylazanium Chemical compound CCCCCCCCCCCC(=O)NCCC[N+](C)(C)CC(O)=O MRUAUOIMASANKQ-UHFFFAOYSA-O 0.000 description 1
- 239000008112 carboxymethyl-cellulose Substances 0.000 description 1
- 150000001746 carotenes Chemical class 0.000 description 1
- 235000005473 carotenes Nutrition 0.000 description 1
- 235000021466 carotenoid Nutrition 0.000 description 1
- 150000001747 carotenoids Chemical class 0.000 description 1
- 230000036232 cellulite Effects 0.000 description 1
- 229940106189 ceramide Drugs 0.000 description 1
- 150000001783 ceramides Chemical class 0.000 description 1
- 229940074979 cetyl palmitate Drugs 0.000 description 1
- 239000002738 chelating agent Substances 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- CWVRJTMFETXNAD-JUHZACGLSA-N chlorogenic acid Chemical compound O[C@@H]1[C@H](O)C[C@@](O)(C(O)=O)C[C@H]1OC(=O)\C=C\C1=CC=C(O)C(O)=C1 CWVRJTMFETXNAD-JUHZACGLSA-N 0.000 description 1
- 229940074393 chlorogenic acid Drugs 0.000 description 1
- 235000001368 chlorogenic acid Nutrition 0.000 description 1
- FFQSDFBBSXGVKF-KHSQJDLVSA-N chlorogenic acid Natural products O[C@@H]1C[C@](O)(C[C@@H](CC(=O)C=Cc2ccc(O)c(O)c2)[C@@H]1O)C(=O)O FFQSDFBBSXGVKF-KHSQJDLVSA-N 0.000 description 1
- BMRSEYFENKXDIS-KLZCAUPSSA-N cis-3-O-p-coumaroylquinic acid Natural products O[C@H]1C[C@@](O)(C[C@@H](OC(=O)C=Cc2ccc(O)cc2)[C@@H]1O)C(=O)O BMRSEYFENKXDIS-KLZCAUPSSA-N 0.000 description 1
- 235000017471 coenzyme Q10 Nutrition 0.000 description 1
- ACTIUHUUMQJHFO-UPTCCGCDSA-N coenzyme Q10 Chemical compound COC1=C(OC)C(=O)C(C\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CCC=C(C)C)=C(C)C1=O ACTIUHUUMQJHFO-UPTCCGCDSA-N 0.000 description 1
- 229920001436 collagen Polymers 0.000 description 1
- 239000003086 colorant Substances 0.000 description 1
- 230000000295 complement effect Effects 0.000 description 1
- 125000001047 cyclobutenyl group Chemical group C1(=CCC1)* 0.000 description 1
- 125000001995 cyclobutyl group Chemical group [H]C1([H])C([H])([H])C([H])(*)C1([H])[H] 0.000 description 1
- 229940097362 cyclodextrins Drugs 0.000 description 1
- 125000002188 cycloheptatrienyl group Chemical group C1(=CC=CC=CC1)* 0.000 description 1
- 125000001162 cycloheptenyl group Chemical group C1(=CCCCCC1)* 0.000 description 1
- 125000000582 cycloheptyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])([H])C([H])(*)C([H])([H])C1([H])[H] 0.000 description 1
- 125000000596 cyclohexenyl group Chemical group C1(=CCCCC1)* 0.000 description 1
- 125000004090 cyclononenyl group Chemical group C1(=CCCCCCCC1)* 0.000 description 1
- 125000006547 cyclononyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])(*)C([H])([H])C([H])([H])C1([H])[H] 0.000 description 1
- 125000000522 cyclooctenyl group Chemical group C1(=CCCCCCC1)* 0.000 description 1
- 125000000640 cyclooctyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])([H])C([H])(*)C([H])([H])C([H])([H])C1([H])[H] 0.000 description 1
- 125000000058 cyclopentadienyl group Chemical group C1(=CC=CC1)* 0.000 description 1
- 125000002433 cyclopentenyl group Chemical group C1(=CCCC1)* 0.000 description 1
- 125000000298 cyclopropenyl group Chemical group [H]C1=C([H])C1([H])* 0.000 description 1
- 230000002950 deficient Effects 0.000 description 1
- 239000007854 depigmenting agent Substances 0.000 description 1
- 210000004207 dermis Anatomy 0.000 description 1
- 150000001983 dialkylethers Chemical class 0.000 description 1
- 150000002009 diols Chemical class 0.000 description 1
- 125000003438 dodecyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
- 239000000975 dye Substances 0.000 description 1
- 229920002549 elastin Polymers 0.000 description 1
- 239000003792 electrolyte Substances 0.000 description 1
- 238000005538 encapsulation Methods 0.000 description 1
- ZSWFCLXCOIISFI-UHFFFAOYSA-N endo-cyclopentadiene Natural products C1C=CC=C1 ZSWFCLXCOIISFI-UHFFFAOYSA-N 0.000 description 1
- 230000007613 environmental effect Effects 0.000 description 1
- 210000002615 epidermis Anatomy 0.000 description 1
- 150000002170 ethers Chemical class 0.000 description 1
- DEFVIWRASFVYLL-UHFFFAOYSA-N ethylene glycol bis(2-aminoethyl)tetraacetic acid Chemical compound OC(=O)CN(CC(O)=O)CCOCCOCCN(CC(O)=O)CC(O)=O DEFVIWRASFVYLL-UHFFFAOYSA-N 0.000 description 1
- 210000002744 extracellular matrix Anatomy 0.000 description 1
- 108091007167 extracellular matrix enzymes Proteins 0.000 description 1
- 102000036444 extracellular matrix enzymes Human genes 0.000 description 1
- 239000000284 extract Substances 0.000 description 1
- 229940043259 farnesol Drugs 0.000 description 1
- 229930002886 farnesol Natural products 0.000 description 1
- 150000002191 fatty alcohols Chemical class 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 239000004872 foam stabilizing agent Substances 0.000 description 1
- 239000008273 gelatin Substances 0.000 description 1
- 229920000159 gelatin Polymers 0.000 description 1
- 235000019322 gelatine Nutrition 0.000 description 1
- 235000011852 gelatine desserts Nutrition 0.000 description 1
- 150000004676 glycans Chemical class 0.000 description 1
- 125000005456 glyceride group Chemical group 0.000 description 1
- 125000003976 glyceryl group Chemical group [H]C([*])([H])C(O[H])([H])C(O[H])([H])[H] 0.000 description 1
- 229940075529 glyceryl stearate Drugs 0.000 description 1
- 239000008266 hair spray Substances 0.000 description 1
- 125000003187 heptyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 238000005570 heteronuclear single quantum coherence Methods 0.000 description 1
- PXDJXZJSCPSGGI-UHFFFAOYSA-N hexadecanoic acid hexadecyl ester Natural products CCCCCCCCCCCCCCCCOC(=O)CCCCCCCCCCCCCCC PXDJXZJSCPSGGI-UHFFFAOYSA-N 0.000 description 1
- 125000004051 hexyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
- 229930195733 hydrocarbon Natural products 0.000 description 1
- 150000002430 hydrocarbons Chemical class 0.000 description 1
- 239000000416 hydrocolloid Substances 0.000 description 1
- 125000002768 hydroxyalkyl group Chemical group 0.000 description 1
- 235000019447 hydroxyethyl cellulose Nutrition 0.000 description 1
- TUJKJAMUKRIRHC-UHFFFAOYSA-N hydroxyl Chemical compound [OH] TUJKJAMUKRIRHC-UHFFFAOYSA-N 0.000 description 1
- 230000004957 immunoregulator effect Effects 0.000 description 1
- 238000011065 in-situ storage Methods 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 230000028709 inflammatory response Effects 0.000 description 1
- 229940030980 inova Drugs 0.000 description 1
- 230000010354 integration Effects 0.000 description 1
- 229940047122 interleukins Drugs 0.000 description 1
- 239000001282 iso-butane Substances 0.000 description 1
- 235000013847 iso-butane Nutrition 0.000 description 1
- 125000004491 isohexyl group Chemical group C(CCC(C)C)* 0.000 description 1
- 125000000555 isopropenyl group Chemical group [H]\C([H])=C(\*)C([H])([H])[H] 0.000 description 1
- 229940089456 isopropyl stearate Drugs 0.000 description 1
- 230000005722 itchiness Effects 0.000 description 1
- 230000007803 itching Effects 0.000 description 1
- 235000015110 jellies Nutrition 0.000 description 1
- 235000014655 lactic acid Nutrition 0.000 description 1
- 239000004310 lactic acid Substances 0.000 description 1
- 229940099367 lanolin alcohols Drugs 0.000 description 1
- 239000000787 lecithin Substances 0.000 description 1
- 235000010445 lecithin Nutrition 0.000 description 1
- 229940067606 lecithin Drugs 0.000 description 1
- 150000002632 lipids Chemical class 0.000 description 1
- 235000019136 lipoic acid Nutrition 0.000 description 1
- AGBQKNBQESQNJD-UHFFFAOYSA-N lipoic acid Chemical compound OC(=O)CCCCC1CCSS1 AGBQKNBQESQNJD-UHFFFAOYSA-N 0.000 description 1
- 239000002502 liposome Substances 0.000 description 1
- 235000010420 locust bean gum Nutrition 0.000 description 1
- 239000000711 locust bean gum Substances 0.000 description 1
- 235000012661 lycopene Nutrition 0.000 description 1
- 229960004999 lycopene Drugs 0.000 description 1
- 239000001751 lycopene Substances 0.000 description 1
- OAIJSZIZWZSQBC-GYZMGTAESA-N lycopene Chemical compound CC(C)=CCC\C(C)=C\C=C\C(\C)=C\C=C\C(\C)=C\C=C\C=C(/C)\C=C\C=C(/C)\C=C\C=C(/C)CCC=C(C)C OAIJSZIZWZSQBC-GYZMGTAESA-N 0.000 description 1
- 239000011777 magnesium Substances 0.000 description 1
- 235000019341 magnesium sulphate Nutrition 0.000 description 1
- 239000004530 micro-emulsion Substances 0.000 description 1
- 239000012184 mineral wax Substances 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 235000011929 mousse Nutrition 0.000 description 1
- 125000003136 n-heptyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
- 125000001280 n-hexyl group Chemical group C(CCCCC)* 0.000 description 1
- HMMGMWAXVFQUOA-UHFFFAOYSA-N octamethylcyclotetrasiloxane Chemical compound C[Si]1(C)O[Si](C)(C)O[Si](C)(C)O[Si](C)(C)O1 HMMGMWAXVFQUOA-UHFFFAOYSA-N 0.000 description 1
- FMJSMJQBSVNSBF-UHFFFAOYSA-N octocrylene Chemical group C=1C=CC=CC=1C(=C(C#N)C(=O)OCC(CC)CCCC)C1=CC=CC=C1 FMJSMJQBSVNSBF-UHFFFAOYSA-N 0.000 description 1
- 229960000601 octocrylene Drugs 0.000 description 1
- 125000002347 octyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 239000002674 ointment Substances 0.000 description 1
- BARWIPMJPCRCTP-UHFFFAOYSA-N oleic acid oleyl ester Natural products CCCCCCCCC=CCCCCCCCCOC(=O)CCCCCCCC=CCCCCCCCC BARWIPMJPCRCTP-UHFFFAOYSA-N 0.000 description 1
- BARWIPMJPCRCTP-CLFAGFIQSA-N oleyl oleate Chemical compound CCCCCCCC\C=C/CCCCCCCCOC(=O)CCCCCCC\C=C/CCCCCCCC BARWIPMJPCRCTP-CLFAGFIQSA-N 0.000 description 1
- 239000004006 olive oil Substances 0.000 description 1
- 235000008390 olive oil Nutrition 0.000 description 1
- 150000007524 organic acids Chemical class 0.000 description 1
- 235000005985 organic acids Nutrition 0.000 description 1
- 239000003960 organic solvent Substances 0.000 description 1
- 230000004792 oxidative damage Effects 0.000 description 1
- 230000036542 oxidative stress Effects 0.000 description 1
- 125000004430 oxygen atom Chemical group O* 0.000 description 1
- 229940094443 oxytocics prostaglandins Drugs 0.000 description 1
- 239000002540 palm oil Substances 0.000 description 1
- 239000012188 paraffin wax Substances 0.000 description 1
- 235000011837 pasties Nutrition 0.000 description 1
- 231100000915 pathological change Toxicity 0.000 description 1
- 230000036285 pathological change Effects 0.000 description 1
- 230000035515 penetration Effects 0.000 description 1
- 125000003538 pentan-3-yl group Chemical group [H]C([H])([H])C([H])([H])C([H])(*)C([H])([H])C([H])([H])[H] 0.000 description 1
- 229940066842 petrolatum Drugs 0.000 description 1
- 235000019271 petrolatum Nutrition 0.000 description 1
- 239000000546 pharmaceutical excipient Substances 0.000 description 1
- 239000012071 phase Substances 0.000 description 1
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 description 1
- 239000010452 phosphate Substances 0.000 description 1
- 230000008845 photoaging Effects 0.000 description 1
- 230000035479 physiological effects, processes and functions Effects 0.000 description 1
- 235000002949 phytic acid Nutrition 0.000 description 1
- 239000000467 phytic acid Substances 0.000 description 1
- 229940068041 phytic acid Drugs 0.000 description 1
- 239000000419 plant extract Substances 0.000 description 1
- 229920002647 polyamide Polymers 0.000 description 1
- 229920000223 polyglycerol Polymers 0.000 description 1
- 229920000642 polymer Polymers 0.000 description 1
- 239000000244 polyoxyethylene sorbitan monooleate Substances 0.000 description 1
- 235000010482 polyoxyethylene sorbitan monooleate Nutrition 0.000 description 1
- 108010084828 polypeptide oleate condensate Proteins 0.000 description 1
- 229920001282 polysaccharide Polymers 0.000 description 1
- 239000005017 polysaccharide Substances 0.000 description 1
- 229920001296 polysiloxane Polymers 0.000 description 1
- 229940068968 polysorbate 80 Drugs 0.000 description 1
- 229920000053 polysorbate 80 Polymers 0.000 description 1
- 229920002451 polyvinyl alcohol Polymers 0.000 description 1
- 229920000036 polyvinylpyrrolidone Polymers 0.000 description 1
- 239000001267 polyvinylpyrrolidone Substances 0.000 description 1
- 235000013855 polyvinylpyrrolidone Nutrition 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- ZPWFUIUNWDIYCJ-UHFFFAOYSA-N propan-2-yl octadecanoate Chemical compound CCCCCCCCCCCCCCCCCC(=O)OC(C)C ZPWFUIUNWDIYCJ-UHFFFAOYSA-N 0.000 description 1
- 239000001294 propane Substances 0.000 description 1
- 125000004368 propenyl group Chemical group C(=CC)* 0.000 description 1
- 150000003180 prostaglandins Chemical class 0.000 description 1
- 238000000425 proton nuclear magnetic resonance spectrum Methods 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 235000019173 retinyl acetate Nutrition 0.000 description 1
- 229940108325 retinyl palmitate Drugs 0.000 description 1
- 235000019172 retinyl palmitate Nutrition 0.000 description 1
- 239000011769 retinyl palmitate Substances 0.000 description 1
- 238000007665 sagging Methods 0.000 description 1
- 208000008742 seborrheic dermatitis Diseases 0.000 description 1
- 239000002453 shampoo Substances 0.000 description 1
- 230000019491 signal transduction Effects 0.000 description 1
- 229920002545 silicone oil Polymers 0.000 description 1
- 210000004927 skin cell Anatomy 0.000 description 1
- 239000004328 sodium tetraborate Substances 0.000 description 1
- 235000010339 sodium tetraborate Nutrition 0.000 description 1
- 210000000434 stratum corneum Anatomy 0.000 description 1
- 230000035882 stress Effects 0.000 description 1
- 108091007196 stromelysin Proteins 0.000 description 1
- CXVGEDCSTKKODG-UHFFFAOYSA-N sulisobenzone Chemical compound C1=C(S(O)(=O)=O)C(OC)=CC(O)=C1C(=O)C1=CC=CC=C1 CXVGEDCSTKKODG-UHFFFAOYSA-N 0.000 description 1
- 229960000368 sulisobenzone Drugs 0.000 description 1
- 230000000475 sunscreen effect Effects 0.000 description 1
- 239000000516 sunscreening agent Substances 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- 230000002195 synergetic effect Effects 0.000 description 1
- 208000009056 telangiectasis Diseases 0.000 description 1
- 229960002663 thioctic acid Drugs 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 229940042585 tocopherol acetate Drugs 0.000 description 1
- 125000002640 tocopherol group Chemical class 0.000 description 1
- 235000019149 tocopherols Nutrition 0.000 description 1
- YXFVVABEGXRONW-JGUCLWPXSA-N toluene-d8 Chemical compound [2H]C1=C([2H])C([2H])=C(C([2H])([2H])[2H])C([2H])=C1[2H] YXFVVABEGXRONW-JGUCLWPXSA-N 0.000 description 1
- 230000001256 tonic effect Effects 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- CRDAMVZIKSXKFV-UHFFFAOYSA-N trans-Farnesol Natural products CC(C)=CCCC(C)=CCCC(C)=CCO CRDAMVZIKSXKFV-UHFFFAOYSA-N 0.000 description 1
- ZCIHMQAPACOQHT-ZGMPDRQDSA-N trans-isorenieratene Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/c1c(C)ccc(C)c1C)C=CC=C(/C)C=Cc2c(C)ccc(C)c2C ZCIHMQAPACOQHT-ZGMPDRQDSA-N 0.000 description 1
- 125000005208 trialkylammonium group Chemical group 0.000 description 1
- LADGBHLMCUINGV-UHFFFAOYSA-N tricaprin Chemical compound CCCCCCCCCC(=O)OCC(OC(=O)CCCCCCCCC)COC(=O)CCCCCCCCC LADGBHLMCUINGV-UHFFFAOYSA-N 0.000 description 1
- 229940040064 ubiquinol Drugs 0.000 description 1
- QNTNKSLOFHEFPK-UPTCCGCDSA-N ubiquinol-10 Chemical compound COC1=C(O)C(C)=C(C\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CCC=C(C)C)C(O)=C1OC QNTNKSLOFHEFPK-UPTCCGCDSA-N 0.000 description 1
- 229940035936 ubiquinone Drugs 0.000 description 1
- 125000000391 vinyl group Chemical group [H]C([*])=C([H])[H] 0.000 description 1
- 229920002554 vinyl polymer Polymers 0.000 description 1
- 235000019155 vitamin A Nutrition 0.000 description 1
- 239000011719 vitamin A Substances 0.000 description 1
- 235000019154 vitamin C Nutrition 0.000 description 1
- 239000011718 vitamin C Substances 0.000 description 1
- 229940045997 vitamin a Drugs 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
- 239000010497 wheat germ oil Substances 0.000 description 1
- 229940118846 witch hazel Drugs 0.000 description 1
- 239000000230 xanthan gum Substances 0.000 description 1
- 229920001285 xanthan gum Polymers 0.000 description 1
- 235000010493 xanthan gum Nutrition 0.000 description 1
- 229940082509 xanthan gum Drugs 0.000 description 1
- OENHQHLEOONYIE-JLTXGRSLSA-N β-Carotene Chemical compound CC=1CCCC(C)(C)C=1\C=C\C(\C)=C\C=C\C(\C)=C\C=C\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C OENHQHLEOONYIE-JLTXGRSLSA-N 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F5/00—Compounds containing elements of Groups 3 or 13 of the Periodic Table
- C07F5/02—Boron compounds
- C07F5/025—Boronic and borinic acid compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/58—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing atoms other than carbon, hydrogen, halogen, oxygen, nitrogen, sulfur or phosphorus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/08—Anti-ageing preparations
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q1/00—Make-up preparations; Body powders; Preparations for removing make-up
- A61Q1/02—Preparations containing skin colorants, e.g. pigments
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q15/00—Anti-perspirants or body deodorants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q17/00—Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
- A61Q17/04—Topical preparations for affording protection against sunlight or other radiation; Topical sun tanning preparations
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/10—Washing or bathing preparations
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q5/00—Preparations for care of the hair
- A61Q5/006—Antidandruff preparations
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Dermatology (AREA)
- Gerontology & Geriatric Medicine (AREA)
- Birds (AREA)
- Cosmetics (AREA)
Abstract
Description
Die Erfindung betrifft die Verwendung von Peroxid-Zersetzern sowie einer Kombination aus Antioxidantien und Peroxid-Zersetzern, die durch Reduktion ohne die Bildung von radikalischen Folgestufen mit den Peroxiden schneller als hauteigene Schwefel enthaltende Verbindungen mit Peroxiden bzw. Hydroperoxiden reagieren, sowie kosmetische und dermatologische Zubereitungen, die diese Peroxid-Zersetzer enthalten. The invention relates to the use of peroxide decomposers and a combination of antioxidants and Peroxide decomposers by reduction without the formation of radicals Subsequent stages with the peroxides faster than the skin's own sulfur containing compounds with peroxides or hydroperoxides react, as well as cosmetic and dermatological preparations, that contain these peroxide decomposers.
Die menschliche Haut unterliegt gewissen Alterungsprozessen, die teilweise auf intrinsische Prozesse (chronoaging) und teilweise auf exogene Faktoren (environmental, z. B. photoaging) zurückzuführen sind. Zusätzlich treten vorübergehende oder auch andauernde Veränderungen des Hautbildes auf, wie Akne, fettige oder trockene Haut, Keratosen, Rosaceae, lichtempfindliche, entzündliche, erythematöse, allergische oder autoimmunreaktive Reaktionen wie Dermatosen, Photodermatosen und andere, deren genaue Ursachen sowie Faktoren, die sie beeinflussen, häufig nur unvollständig verstanden sind. The human skin is subject to certain aging processes, which partly relate to intrinsic processes (chronoaging) and partly due to exogenous factors (environmental, e.g. photoaging) are due. Additionally occur temporarily or also permanent changes in the complexion, such as acne, oily or dry skin, keratosis, rosaceae, photosensitive, inflammatory, erythematous, allergic or autoimmune reactive Reactions such as dermatoses, photodermatoses and others, their exact causes, as well as factors that influence them, often are only partially understood.
Zu den exogenen Faktoren zählen insbesondere das Sonnenlicht oder künstliche Strahlungsquellen mit vergleichbarem Spektrum, sowie Verbindungen, die durch die Strahlung entstehen können, wie undefinierte reaktive Photoprodukte, die auch radikalisch oder ionisch sein können. Zu diesen Faktoren zählen aber auch schädliche oder reaktive Verbindungen wie Ozon, freie Radikale, beispielsweise das Hydroxylradikal, Singulettsauerstoff und andere reaktive Sauerstoff- oder Stickstoffverbindungen, Zigarettenrauch, natürliche und synthetische Toxine, und andere, die die natürliche Physiologie oder Morphologie der Haut stören. Durch den Einfluss dieser Faktoren kommt es unter anderem zu direkten Schäden an der DNA der Hautzellen sowie den Kollagen-, Elastin- oder Glycosaminoglycanmolekülen der extrazellulären Matrix, die für die Festigkeit der Haut verantwortlich sind. Darüberhinaus werden Signaltransduktionsketten beeinflusst, an deren Ende die Aktivierung schädlicher Faktoren, z. B. matrixabbauender Enzyme, steht. Wichtige Vertreter dieser Enzyme sind die Matrixmetalloproteinasen (MMPs, z. B. Kollagenasen, Gelatinasen, Stromelysine), deren Aktivität zusätzlich durch TIMPs (tissue inhibitor of matrix metalloproteinases) reguliert werden. The exogenous factors include, in particular, sunlight or artificial radiation sources with a comparable spectrum, as well Compounds that can arise from the radiation, such as undefined reactive photo products, which are also radical or can be ionic. But these factors also count harmful or reactive compounds such as ozone, free radicals, for example the hydroxyl radical, singlet oxygen and others reactive oxygen or nitrogen compounds, Cigarette smoke, natural and synthetic toxins, and others that disrupt natural physiology or morphology of the skin. By Among other things, the influence of these factors leads to direct Damage to the DNA of the skin cells as well as the collagen, elastin or glycosaminoglycan molecules of the extracellular matrix which are responsible for the firmness of the skin. Furthermore signal transduction chains are influenced, at the end of which the Activation of harmful factors, e.g. B. matrix-degrading enzymes, stands. Important representatives of these enzymes are Matrix metalloproteinases (MMPs, e.g. collagenases, gelatinases, stromelysins), whose activity is additionally determined by TIMPs (tissue inhibitor of matrix metalloproteinases) can be regulated.
Weiter kommt es durch die schädlichen Einflüsse zu Schäden an den Zellen der Haut selbst. Als Folge hiervon ist beispielsweise die Regenerationsfähigkeit der Haut verringert. Furthermore, the harmful influences lead to damage on the cells of the skin itself. As a result of this is For example, the skin's ability to regenerate is reduced.
Als weitere Folge kann es zu entzündlichen Reaktionen kommen, unter anderem werden immunregulatorische Verbindungen, wie Interleukine, Prostaglandine und Histamine ausgeschüttet. Dadurch werden unter anderem immunkompetente Zellen angelockt und die entzündliche Reaktion verstärkt. As a further consequence, inflammatory reactions can occur among other things, immunoregulatory compounds such as Interleukins, prostaglandins and histamines released. This attracts immunocompetent cells, among other things and intensifies the inflammatory response.
Die Folgen der Alterung sind Verdünnung der Haut, schwächere Verzahnung von Epidermis und Dermis, Reduktion der Zellzahl sowie der versorgenden Blutgefäße. Durch die Alterungsprozesse kommt es zur Ausbildung von feinen Linien und Falten, die Haut wird ledrig, gelblich und herabhängend, es treten Pigmentstörungen auf. The consequences of aging are thinning of the skin, weaker Interlocking of the epidermis and dermis, reduction in the number of cells and the supplying blood vessels. Through the aging processes fine lines and wrinkles develop Skin becomes leathery, yellowish and sagging, it occurs Pigment disorders.
Antioxidativ wirksame Verbindungen werden häufig in dermatologischen oder kosmetischen Zubereitungen zum Schutz gegen den Verderb eingesetzt. Darüber hinaus können sie aber auch eingesetzt werden, um schädliche oder unerwünschte oxidative Prozesse, die in der menschlichen oder tierischen Haut ablaufen, zu verringern. Es ist bekannt, dass derartige Prozesse bei der Hautalterung eine bedeutsame Rolle spielen. Die Haut ist permanent oxidativem Stress durch die Bildung von Peroxiden und Hydroperoxiden ausgesetzt, die zum Teil aus der äußeren Umgebung der Haut stammen, zum Teil aber auch endogen gebildet werden. Um diesem Stress zu begegnen, besitzt die Haut eine Vielzahl eigener Schutzmechanismen. Diese Schutzmechanismen reichen jedoch nicht aus, um oxidative Prozesse in der Haut vollständig zu verhindern. Es wird im Gegenteil allgemein angenommen, dass eben diese oxidativen Prozesse einen wesentlichen Beitrag zur Hautalterung, aber auch zu allgemeinen oder krankhaften Veränderungen der Haut leisten. Antioxidant compounds are often found in dermatological or cosmetic preparations for protection against used the spoil. But they can also used to be harmful or undesirable oxidative Processes that take place in human or animal skin, to reduce. It is known that such processes occur in play an important role in skin aging. The skin is permanent oxidative stress through the formation of peroxides and Exposed to hydroperoxides, some from the outside environment derive from the skin, but are also partially formed endogenously. Around To counteract this stress, the skin has a large number of its own Protections. However, these protective mechanisms are not enough to completely prevent oxidative processes in the skin. On the contrary, it is generally assumed that it is these oxidative processes make a significant contribution to skin aging, but also to general or pathological changes in the skin Afford.
Insbesondere ist die Bedeutung der Lipidperoxidation für die Alterung allgemein anerkannt. Auch die toxische Wirkung von Lipidhydroperoxiden und deren Zersetzungsprodukten wurde u. a. von W. A. Prior (ACS Sysup. Ser. (1985), 277, 77-96) beschrieben. Zur Zersetzung von Peroxiden, Hydroperoxiden oder Wasserstoffperoxid sind verschiedene Systeme auch im Zusammenhang mit Kosmetik beschrieben worden, so die Verwendung von Metallphosphyrinen (JP 3273082), Phytinsäurezinksalzen (JP 08104635), Katalase (JP 08175035) und anderen Enzymen (JP 67165553). Ferner ist aus JP 06345797 die Verwendung von Cystein-haltigen Dipeptiden zur Hautbleichung, zur Verhinderung der Lipidperoxidation und zur Zersetzung von Lipidperoxiden bekannt. In particular, the importance of lipid peroxidation for the Aging generally recognized. The toxic effects of Lipid hydroperoxides and their decomposition products have been u. a. by W. A. Prior (ACS Sysup. Ser. (1985), 277, 77-96). For the decomposition of peroxides, hydroperoxides or Hydrogen peroxide are also related to various systems Cosmetics have been described, so the use of Metal phosphyrins (JP 3273082), phytic acid zinc salts (JP 08104635), Catalase (JP 08175035) and other enzymes (JP 67165553). Furthermore, JP 06345797 describes the use of cysteine-containing Dipeptides for bleaching the skin, for preventing Lipid peroxidation and for the decomposition of lipid peroxides known.
Zur Unterstützung der endogenen Schutzmechanismen werden deshalb antioxidativ, d. h. als O- oder C-Radikalfänger, wirksame Bestandteile zu kosmetischen und dermatologischen Zubereitungen zugesetzt (z. B. DE 197 39 349). Allerdings bleibt bislang die tatsächlich erzielte Wirkung hinter der erhofften zurück. Insbesondere lässt sich durch Steigerung der zugesetzten Menge des Antioxidans in der Regel kein entsprechend höherer antioxydativer Effekt erzielen. To support the endogenous protective mechanisms therefore antioxidant, d. H. effective as O or C radical scavengers Ingredients for cosmetic and dermatological preparations added (e.g. DE 197 39 349). So far, however effect actually achieved behind the hoped for. In particular, by increasing the amount of Antioxidant usually not a correspondingly higher antioxidant Achieve effect.
Es bestand daher die Aufgabe, Wirkstoffe für kosmetische oder dermatologische Zubereitungen bereitzustellen, mit denen sich die antioxydative Wirkung erheblich steigern lässt. It was therefore the task of active ingredients for cosmetic or to provide dermatological preparations with which can significantly increase the antioxidant effect.
Weiterhin bestand die Aufgabe, Wirkstoffe für kosmetische oder dermatologische Zubereitungen bereitzustellen, welche die Haut vor oxidativen Schäden schützt. There was also the task of active ingredients for cosmetic or dermatological preparations to provide the skin protects against oxidative damage.
Generell gilt für den Mechanismus der Peroxid- bzw. Hydroperoxid-
Bildung das folgende Schema
In general, the following scheme applies to the mechanism of peroxide or hydroperoxide formation
Während die üblichen Antioxidantien im wesentlichen O- bzw.
C-Radikalfänger sind, lag der Erfindung die Aufgabe zugrunde,
durch weitere Maßnahmen durch Eingriff im Mechanismus dieses
Schemas zusätzlich an einer anderen Stelle Hautschäden
effizienter zu verhindern. Dazu wurde ein ionisch und reduzierend
wirkender Angriff nach dem folgenden Schema in Betracht gezogen.
While the usual antioxidants are essentially O or C radical scavengers, the object of the invention was to prevent skin damage more efficiently by intervening in the mechanism of this scheme. An ionic and reducing attack according to the following scheme was considered.
Es wurde nun gefunden, dass die Verwendung eines reduzierend wirkenden Peroxidzersetzers eine ausgezeichnete Wirkung hat. Weiterhin wurde gefunden, dass die Verwendung einer Kombination eines Antioxidans als Radikalfänger und eines reduzierend wirkenden Peroxidzersetzers eine ausgezeichnete synergistische Wirkung hat. Dabei muss der Peroxidzersetzer so gewählt werden, dass er in vitro deutlich reaktiver ist, als entsprechend wirkende hauteigene, Schwefel enthaltende Verbindungen, wie Cystin oder Cystein. It has now been found that the use of a reducing acting peroxide decomposer has an excellent effect. It was also found that the use of a combination one antioxidant as a radical scavenger and one reducing acting peroxide decomposer an excellent synergistic Has an effect. The peroxide decomposer must be selected so that that it is significantly more reactive in vitro than it is acting skin's own, sulfur-containing compounds, such as Cystine or cysteine.
Insbesondere wurde die oben beschriebene Aufgabe gelöst
mit kosmetischen oder dermatologischen Zubereitungen, die
einen wirksamen Gehalt von
- a) mindestens einem als O- bzw. C-Radikal-Scavenger wirksamen Antioxidans und
- b) mindestens einer organischen, Bor-enthaltenden Verbindung, die Peroxide oder Hydroperoxide zu den entsprechenden Alkoholen ohne Bildung aktiver radikalischer Folgestufen reduziert.
- a) at least one antioxidant effective as an O- or C-radical scavenger and
- b) at least one organic, boron-containing compound which reduces peroxides or hydroperoxides to the corresponding alcohols without the formation of active radical subsequent steps.
Die erfindungsgemäßen Zubereitungen eignen sich insbesondere zur Vermeidung bzw. Verminderung von Hautschäden durch endogen oder exogen gebildete Peroxide oder Hydroperoxide. The preparations according to the invention are particularly suitable to avoid or reduce skin damage caused by endogenous or exogenously formed peroxides or hydroperoxides.
Die kosmetischen oder dermatologischen Zubereitungen enthalten in der Regel, bezogen auf die fertigen Zubereitungen, 0,001 bis 30 Gew.-%, vorzugsweise 0,01 bis 10 Gew.-% und insbesondere 1 bis 5 Gew.-% Antioxidans (a) und 0,001 bis 30 Gew.-%, vorzugsweise 0,01 bis 10 Gew.-% und insbesondere 1 bis 5 Gew.-% mindestens eines Peroxid- bzw. Hydroperoxid-Zersetzers (b). Contain the cosmetic or dermatological preparations usually, based on the finished preparations, 0.001 to 30% by weight, preferably 0.01 to 10% by weight and in particular 1 to 5% by weight of antioxidant (a) and 0.001 to 30% by weight, preferably 0.01 to 10 wt .-% and in particular 1 to 5 wt .-% at least a peroxide or hydroperoxide decomposer (b).
Die Peroxid- bzw. Hydroperoxid-Zersetzer (b) weisen eine deutlich größere zersetzende (reduzierende) Wirkung als hauteigene Verbindungen wie Cystin oder Cystein aufweisen. Ob sich bestimmte Verbindungen für die erfindungsgemäße Verwendung eignen, erkennt man in vitro z. B. daran, dass sie bei Raumtemperatur, gelöst in einer molaren Konzentration von 0,05 m/l in einem polaren oder unpolaren Lösungsmittel nach einer Lagerung bei 70°C für 30 Minuten die Peroxid- bzw. Hydroperoxid-Konzentration um mindestens 10%, insbesondere 20%, vorzugsweise 50% und insbesondere 90% herabsetzen. The peroxide or hydroperoxide decomposers (b) have one significantly greater decomposing (reducing) effect than the skin's own Have compounds such as cystine or cysteine. Whether certain Suitable compounds for the use according to the invention, recognizes one in vitro z. B. that they are dissolved at room temperature in a molar concentration of 0.05 m / l in a polar or non-polar solvent after storage at 70 ° C for 30 minutes the peroxide or hydroperoxide concentration around at least 10%, in particular 20%, preferably 50% and reduce in particular 90%.
Ein weiterer Gegenstand der vorliegenden Erfindung betrifft die Verwendung von organischen, Bor-enthaltenden Verbindungen b), die Peroxide oder Hydroperoxide zu den entsprechenden Alkoholen ohne Bildung aktiver radikalischer Folgestufen reduziert, in kosmetischen oder dermatologischen Zubereitungen. Another object of the present invention relates to Use of organic, boron-containing compounds b), the peroxides or hydroperoxides to the corresponding alcohols reduced without the formation of active radical subsequent stages, in cosmetic or dermatological preparations.
Ein weiterer Gegenstand betrifft die Verwendung einer Kombination
von
- a) mindestens einem als O- bzw. C-Radikal-Scavenger wirksamen Antioxidans und
- b) mindestens einer organischen, Bor-enthaltenden Verbindung, die Peroxide oder Hydroperoxide zu den entsprechenden Alkoholen ohne Bildung reaktiver radikalischer Folgestufen reduziert
- a) at least one antioxidant effective as an O- or C-radical scavenger and
- b) at least one organic, boron-containing compound which reduces peroxides or hydroperoxides to the corresponding alcohols without the formation of reactive radical subsequent steps
In einzelnen kommen als geeignete Bor-enthaltende Verbindungen b) Verbindungen der Formel (I) in
Betracht
in der die variablen unabhängig voneinander folgende Bedeutung haben:
R1, R2 und R3:
Wasserstoff, C1-C20-Alkyl, C2-C10-Alkenyl, C3-C10-Cycloalkyl, C3-C10-Cycloalkenyl, C1-C12-Alkoxy,
C1-C20-Alkoxycarbonyl, C1-C12-Alkylamino, C1-C12-Dialkylamino, Aryl, Heteroaryl, gegebenenfalls
substituiert.
In particular, suitable boron-containing compounds b) are compounds of the formula (I)
in which the variables have the following meaning independently of one another:
R 1 , R 2 and R 3 :
Hydrogen, C 1 -C 20 alkyl, C 2 -C 10 alkenyl, C 3 -C 10 cycloalkyl, C 3 -C 10 cycloalkenyl, C 1 -C 12 alkoxy, C 1 -C 20 alkoxycarbonyl, C 1 -C 12 alkylamino, C 1 -C 12 dialkylamino, aryl, heteroaryl, optionally substituted.
Beispiele für Verbindungen der Formel (I) sind:
Examples of compounds of the formula (I) are:
Geeignet als b) sind weiterhin Verbindungen der Formel (II):
in der R1 die oben angegebene Bedeutung besitzt.
Also suitable as b) are compounds of the formula (II):
in which R 1 has the meaning given above.
Beispiele für Verbindungen der Formel (II) sind:
Examples of compounds of the formula (II) are:
Geeignet als b) sind Verbindungen der Formel (III):
in der R1 und R2 die oben angegebene Bedeutung besitzen.
Suitable as b) are compounds of the formula (III):
in which R 1 and R 2 have the meaning given above.
Beispiele für Verbindungen der Formel (III) sind:
Examples of compounds of the formula (III) are:
Geeignet als b) sind Verbindungen der Formel (IV):
in der R1 und R2 die oben angegebene Bedeutung besitzen und R1 und R2 durch Ringschluss verbrückt sein
können.
Suitable as b) are compounds of the formula (IV):
in which R 1 and R 2 have the meaning given above and R 1 and R 2 can be bridged by ring closure.
Geeignet als b) sind Verbindungen der Formel (V):
in der R1, R2 und R3 die oben angegebene Bedeutung besitzen.
Suitable as b) are compounds of the formula (V):
in which R 1 , R 2 and R 3 have the meaning given above.
Beispiele für Verbindungen der Formel (V) sind:
Examples of compounds of the formula (V) are:
Geeignet als b) sind Verbindungen der Formel (VI):
in der R1, R2 und R3 die oben angegebenen Bedeutungen besitzen.
Compounds of the formula (VI) are suitable as b):
in which R 1 , R 2 and R 3 have the meanings given above.
Beispiele für Verbindungen der Formel (VI) sind:
Examples of compounds of the formula (VI) are:
Geeignet als b) sind Verbindungen der Formel (VII):
in der R1, R2 und R3 die oben angegebenen Bedeutungen besitzen.
Suitable as b) are compounds of the formula (VII):
in which R 1 , R 2 and R 3 have the meanings given above.
Beispiele für Verbindungen der Formel VII sind:
Examples of compounds of the formula VII are:
Geeignet als b) sind Verbindungen der Formel (VIII):
in der die Variablen unabhängig voneinander die folgende Bedeutung haben:
R1, R2, R3 und R4
Wasserstoff, C1-C20-Alkyl, C2-C10-Alkenyl, C3-C10-Cycloalkyl, C3-C10-Cycloalkenyl, C1-C12-Alkoxy,
C1-C20-Alkoxycarbonyl, C1-C12-Alkylamino, C1-C12-Dialkylamino, Aryl, Heteroaryl, gegebenenfalls
substituiert
X⊕ physiologisch verträgliche Kationen, wie die Alkali- und Erdalkalisalze oder wie gegebenenfalls
substituierte Ammoniumsalze.
Suitable as b) are compounds of the formula (VIII):
in which the variables have the following meaning independently of one another:
R 1 , R 2 , R 3 and R 4 are hydrogen, C 1 -C 20 alkyl, C 2 -C 10 alkenyl, C 3 -C 10 cycloalkyl, C 3 -C 10 cycloalkenyl, C 1 -C 12 Alkoxy, C 1 -C 20 alkoxycarbonyl, C 1 -C 12 alkylamino, C 1 -C 12 dialkylamino, aryl, heteroaryl, optionally substituted
X⊕ physiologically compatible cations, such as the alkali and alkaline earth metal salts or as optionally substituted ammonium salts.
Beispiele für Verbindungen der Formel (VIII) sind:
Examples of compounds of the formula (VIII) are:
Als Alkylreste R1 bis R4 seien verzweigte oder unverzweigte C1-C20-Alkylketten, bevorzugt Methyl, Ethyl, n-Propyl, 1-Methylethyl, n-Butyl, 1-Methylpropyl-, 2-Methylpropyl, 1,1-Dimethylethyl, n-Pentyl, 1-Methylbutyl, 2-Methylbutyl, 3-Methylbutyl, 2,2-Dimethylpropyl, 1-Ethylpropyl, n-Hexyl, 1,1-Dimethylpropyl, 1,2-Dimethylpropyl, 1-Methylpentyl, 2-Methylpentyl, 3-Methylpentyl, 4-Methylpentyl, 1,1-Dimethylbutyl, 1,2-Dimethylbutyl, 1,3-Dimethylbutyl, 2,2-Dimethylbutyl, 2,3-Dimethylbutyl, 3,3-Dimethylbutyl, 1-Ethylbutyl, 2-Ethylbutyl, 1,1,2-Trimethylpropyl, 1,2,2-Trimethylpropyl, 1-Ethyl-1-methylpropyl, 1-Ethyl-2-methylpropyl, n-Heptyl, n-Octyl, 2-Ethylhexyl, n-Nonyl, n-Decyl, n-Undecyl, n-Dodecyl, n-Tridecyl, n-Tetradecyl, n-Pentadecyl, n-Hexadecyl, n-Heptadecyl, n-Octadecyl, n-Nonadecyl oder n-Eicosyl genannt. As alkyl radicals R 1 to R 4 are branched or unbranched C 1 -C 20 alkyl chains, preferably methyl, ethyl, n-propyl, 1-methylethyl, n-butyl, 1-methylpropyl, 2-methylpropyl, 1,1-dimethylethyl , n-pentyl, 1-methylbutyl, 2-methylbutyl, 3-methylbutyl, 2,2-dimethylpropyl, 1-ethylpropyl, n-hexyl, 1,1-dimethylpropyl, 1,2-dimethylpropyl, 1-methylpentyl, 2-methylpentyl , 3-methylpentyl, 4-methylpentyl, 1,1-dimethylbutyl, 1,2-dimethylbutyl, 1,3-dimethylbutyl, 2,2-dimethylbutyl, 2,3-dimethylbutyl, 3,3-dimethylbutyl, 1-ethylbutyl, 2 -Ethylbutyl, 1,1,2-trimethylpropyl, 1,2,2-trimethylpropyl, 1-ethyl-1-methylpropyl, 1-ethyl-2-methylpropyl, n-heptyl, n-octyl, 2-ethylhexyl, n-nonyl , n-decyl, n-undecyl, n-dodecyl, n-tridecyl, n-tetradecyl, n-pentadecyl, n-hexadecyl, n-heptadecyl, n-octadecyl, n-nonadecyl or n-eicosyl.
Als besonders bevorzugte Alkylreste seien genannt Methyl, Ethyl, n-Propyl, 1-Methylethyl, n-Butyl, 1-Methylpropyl-, 2-Methylpropyl, 1,1-Dimethylethyl, n-Pentyl, 1-Methylbutyl, 2-Methylbutyl, 3-Methylbutyl, 2,2-Dimethylpropyl, 2-Ethylhexyl genannt. Particularly preferred alkyl radicals are methyl, ethyl, n-propyl, 1-methylethyl, n-butyl, 1-methylpropyl, 2-methylpropyl, 1,1-dimethylethyl, n-pentyl, 1-methylbutyl, 2-methylbutyl, 3-methylbutyl, 2,2-dimethylpropyl, 2-ethylhexyl.
Als Alkenylreste R1 bis R4 seien verzweigte oder unverzweigte C2-C10-Alkenylketten, bevorzugt Vinyl, Propenyl, Isopropenyl, 1-Butenyl, 2-Butenyl, 1-Pentenyl, 2-Pentenyl, 2-Methyl-1-butenyl, 2-Methyl-2-butenyl, 3-Methyl-1-butenyl, 1-Hexenyl, 2-Hexenyl, 1-Heptenyl, 2-Heptenyl, 1-Octenyl oder 2-Octenyl genannt. As alkenyl radicals R 1 to R 4 are branched or unbranched C 2 -C 10 alkenyl chains, preferably vinyl, propenyl, isopropenyl, 1-butenyl, 2-butenyl, 1-pentenyl, 2-pentenyl, 2-methyl-1-butenyl, 2-methyl-2-butenyl, 3-methyl-1-butenyl, 1-hexenyl, 2-hexenyl, 1-heptenyl, 2-heptenyl, 1-octenyl or 2-octenyl.
Als Cycloalkylreste seien für R1 bis R4 bevorzugt verzweigte oder unverzweigte C3-C10-Cycloalkylketten wie Cyclopropyl, Cyclobutyl, Cyclopentyl, Cyclohexyl, Cycloheptyl, 1-Methylcyclopropyl, 1-Ethylcyclopropyl, 1-Propylcyclopropyl, 1-Butylcyclopropyl, 1-Pentylcyclopropyl, 1-Methyl-1-Butylcyclopropyl, 1,2-Dimethylcyclypropyl, 1-Methyl-2-Ethylcyclopropyl, Cyclooctyl, Cyclononyl oder Cyclodecyl genannt. Preferred cycloalkyl radicals for R 1 to R 4 are branched or unbranched C 3 -C 10 cycloalkyl chains such as cyclopropyl, cyclobutyl, cyclopentyl, cyclohexyl, cycloheptyl, 1-methylcyclopropyl, 1-ethylcyclopropyl, 1-propylcyclopropyl, 1-butylcyclopropyl, 1-pentylcyclopropyl Called 1-methyl-1-butylcyclopropyl, 1,2-dimethylcyclypropyl, 1-methyl-2-ethylcyclopropyl, cyclooctyl, cyclononyl or cyclodecyl.
Als Cycloalkenylreste seien für R1 bis R4 bevorzugt verzweigte oder unverzweigte, C3-C10-Cycloalkenylketten mit einer oder mehreren Doppelbindungen wie Cyclopropenyl, Cyclobutenyl, Cyclopentenyl, Cyclopentadienyl, Cyclohexenyl, 1,3-Cyclohexadienyl, 1,4-Cyclohexadienyl, Cycloheptenyl, Cycloheptatrienyl, Cyclooctenyl, 1,5-Cyclooctadienyl, Cyclooctatetraenyl, Cyclononenyl oder Cyclodecyl genannt. Preferred cycloalkenyl radicals for R 1 to R 4 are branched or unbranched, C 3 -C 10 cycloalkenyl chains with one or more double bonds, such as cyclopropenyl, cyclobutenyl, cyclopentenyl, cyclopentadienyl, cyclohexenyl, 1,3-cyclohexadienyl, 1,4-cyclohexadienyl, cycloheptenyl , Cycloheptatrienyl, Cyclooctenyl, 1,5-Cyclooctadienyl, Cyclooctatetraenyl, Cyclononenyl or Cyclodecyl called.
Besonders bevorzugt sind Cyclopropyl, Cyclopentyl und Cyclohexyl. Die Cycloalkenyl- und Cycloalkylreste können ggf. mit einem oder mehreren, z. B. 1 bis 3 Resten wie Halogen z. B. Fluor, Chlor oder Brom, Cyano, Nitro, Amino, C1-C4-Alkylamino, C1-C4-Dialkylamino, Hydroxy, C1-C4-Alkyl, C1-C4-Alkoxy oder anderen Resten substituiert sein oder 1 bis 3 Heteroatome wie Schwefel, Stickstoff, dessen freie Valenzen durch Wasserstoff oder C1-C4-Alkyl abgesättigt sein können oder Sauerstoff im Ring enthalten. Cyclopropyl, cyclopentyl and cyclohexyl are particularly preferred. The cycloalkenyl and cycloalkyl radicals can optionally with one or more, for. B. 1 to 3 radicals such as halogen z. B. fluorine, chlorine or bromine, cyano, nitro, amino, C 1 -C 4 alkylamino, C 1 -C 4 dialkylamino, hydroxy, C 1 -C 4 alkyl, C 1 -C 4 alkoxy or other radicals be substituted or 1 to 3 heteroatoms such as sulfur, nitrogen, the free valences of which may be saturated by hydrogen or C 1 -C 4 -alkyl or contain oxygen in the ring.
Als Alkoxyreste für kommen solche mit 1 bis 12 C-Atomen, vorzugsweise mit 1 bis 8 C-Atomen in Betracht. As alkoxy radicals for those with 1 to 12 carbon atoms, preferably with 1 to 8 carbon atoms.
Beispielsweise sind zu nennen:
Methoxy-
Isopropoxy-
1-Methylpropoxy-
n-Pentoxy-
3-Methylbutoxy-
2,2-Dimethylpropoxy-
1-Methyl-1-ethylpropoxy-
Octoxy-
Ethoxy-
n-Propoxy-
n-Butoxy-
2-Methylpropoxy-
1,1-Dimethylpropoxy-
Hexoxy-
Heptoxy-
2-Ethylhexoxy-
Alkoxycarbonylreste sind z. B. Ester, die die oben genannten
Alkoxyreste oder Reste von höheren Alkoholen z. B. mit bis zu
20 C-Atomen, wie iso-C15-Alkohol, enthalten.
Examples include:
methoxy
isopropoxy
1-Methylpropoxy-
n-pentoxy
3-methylbutoxy
2,2-dimethylpropoxy
1-methyl-1-ethylpropoxy
octyloxy
ethoxy
n-propoxy
n-butoxy
2-Methylpropoxy-
1,1-dimethylpropoxy
hexoxy
heptoxy
2-Ethylhexoxy-
Alkoxycarbonyl radicals are e.g. B. esters, the above-mentioned alkoxy radicals or residues of higher alcohols such. B. with up to 20 carbon atoms, such as iso-C 15 alcohol.
Als Mono- oder Dialkylaminoreste kommen solche in Betracht, die Alkylreste mit 1 bis 12 C-Atomen enthalten, wie z. B. Methyl-, n-Propyl-, n-Butyl-, 2-Methylpropyl-, 1,1-Dimethylpropyl-, Hexyl-, Heptyl-, 2-Ethylhexyl-, Isopropyl-, 1-Methylpropyl-, n-Pentyl-, 3-Methylbutyl-, 2,2-Dimethylpropyl-, 1-Methyl-1-ethylpropyl- und Octyl. Suitable mono- or dialkylamino residues are those which Contain alkyl radicals with 1 to 12 carbon atoms, such as. B. methyl, n-propyl, n-butyl, 2-methylpropyl, 1,1-dimethylpropyl, Hexyl, heptyl, 2-ethylhexyl, isopropyl, 1-methylpropyl, n-pentyl, 3-methylbutyl, 2,2-dimethylpropyl, 1-methyl-1-ethylpropyl and octyl.
Unter Aryl sind aromatische Ringe oder Ringsysteme mit 6 bis 18 Kohlenstoffatomen im Ringsystem zu verstehen, beispielsweise Phenyl oder Naphthyl, die ggf. mit einem oder mehreren Resten wie Halogen z. B. Fluor, Chlor oder Brom, Cyano, Nitro, Amino, C1-C4-Alkylamino, C1-C4-Dialkylamino, Hydroxy, C1-C4-Alkyl, C1-C4-Alkoxy oder anderen Resten substituiert sein können. Bevorzugt sind ggf. substituiertes Phenyl, Methoxyphenyl und Naphthyl. Aryl is to be understood as meaning aromatic rings or ring systems with 6 to 18 carbon atoms in the ring system, for example phenyl or naphthyl, which may have one or more radicals such as halogen, for. B. fluorine, chlorine or bromine, cyano, nitro, amino, C 1 -C 4 alkylamino, C 1 -C 4 dialkylamino, hydroxy, C 1 -C 4 alkyl, C 1 -C 4 alkoxy or other radicals can be substituted. Optionally substituted phenyl, methoxyphenyl and naphthyl are preferred.
Heteroaryl-Reste sind vorteilhafterweise einfache oder kondensierte aromatische Ringsysteme mit einem oder mehreren heteroaromatischen 3- bis 7-gliedrigen Ringen. Als Heteroatome können ein oder mehrere Stickstoff-, Schwefel- und/oder Sauerstoffatome im Ring oder Ringsystem enthalten sein. Heteroaryl residues are advantageously simple or condensed aromatic ring systems with one or more heteroaromatic 3- to 7-membered rings. As heteroatoms can one or more nitrogen, sulfur and / or oxygen atoms be contained in the ring or ring system.
Als physiologisch verträgliche Kationen sind die Kationen der Alkali- und Erdalkalisalze oder der gegebenenfalls substituierte Ammoniumsalze geeignet. Beispielsweise seien genannt die Trialkylammoniumsalze, wie Tri-(hydroxyalkyl)-ammoniumsalze oder die 2-Methylpropan-1-ol-2-ammoniumsalze. Ferner kommen Ammoniumreste, insbesondere Alkylammoniumreste in Betracht. As physiologically compatible cations, the cations are the Alkali and alkaline earth metal salts or the optionally substituted Suitable ammonium salts. Examples include those Trialkylammonium salts, such as tri (hydroxyalkyl) ammonium salts or the 2-methyl propane-1-ol-2-ammonium salts. There are also ammonium residues especially alkylammonium residues.
Die Auswahl aus den vorgenannten Verbindung erfolgt über die Bedingungen der Hautverträglichkeit bzw. der hautverträglichen Konzentration und der Wirksamkeit der Peroxid- bzw. Hydroperoxid- Zersetzung. Dazu löst man die in Betracht kommende Verbindung in einem polaren Lösungsmittel (z. B. Essigsäure) bzw. einem unpolaren Lösungsmittel (z. B. Toluol) in einer molaren Konzentration von 0,05 m/l und misst die Zersetzungsgeschwindigkeit von einem Peroxid bzw. Hydroperoxid nach Lagerung bei 70°C für 30 Minuten. Dabei soll die Konzentration des Peroxids bzw. Hydroperoxids um mindestens 10%, insbesondere 20%, vorzugsweise 50% und insbesondere 90% erniedrigt sein. The selection from the aforementioned connection is made via the Conditions of skin compatibility or skin compatible Concentration and the effectiveness of the peroxide or hydroperoxide Decomposition. To do this, release the connection in question a polar solvent (e.g. acetic acid) or a non-polar solvent (e.g. toluene) in a molar concentration of 0.05 m / l and measures the rate of decomposition of one Peroxide or hydroperoxide after storage at 70 ° C for 30 minutes. The concentration of the peroxide or hydroperoxide should by at least 10%, in particular 20%, preferably 50% and in particular 90% lower.
Die Antioxidantien (a) sind in der Regel an sich bekannte Verbindungen. Vorteilhaft werden die Antioxidantien ausgewählt aus den Gruppen der Carotinoide, Carotine (z. B. α-Carotin, β-Carotin, Lycopin) und deren Derivate, Chlorogensäure und deren Derivate, Liponsäure und deren Derivate (z. B. Dihydroliponsäure), ferner (Metall)Chelatoren, EDTA, EGTA und deren Derivate, Ubichinon und Ubichinol und deren Derivate, Vitamin C und Derivate (z. B. Ascorbylpalmitat, Mg-Ascorbylphosphat, Ascorbylacetat), Tocopherole und Derivate (z. B. Vitamin-E-acetat), Vitamin A und Derivate (Vitamin-A-palmitat), Butylhydroxytoluol, Butylhydroxyanisol, sowie weitere üblicherweise in kosmetischen Zubereitungen verwendete Antioxidantien. The antioxidants (a) are generally known per se Links. The antioxidants are advantageously selected from the groups of carotenoids, carotenes (e.g. α-carotene, β-carotene, Lycopene) and their derivatives, chlorogenic acid and their derivatives, Lipoic acid and its derivatives (e.g. dihydrolipoic acid), furthermore (Metal) chelators, EDTA, EGTA and their derivatives, ubiquinone and ubiquinol and their derivatives, vitamin C and derivatives (e.g. Ascorbyl palmitate, Mg ascorbyl phosphate, ascorbyl acetate), Tocopherols and derivatives (e.g. vitamin E acetate), vitamin A and Derivatives (vitamin A palmitate), butylated hydroxytoluene, Butylated hydroxyanisole, as well as others usually in cosmetic preparations antioxidants used.
Die Menge der vorgenannten Antioxidantien (a) in den fertigen Zubereitungen beträgt z. B. 0,001 bis 30 Gew.-%, vorzugsweise 0,01 bis 10 Gew.-% und insbesondere 1 bis 5 Gew.-%. The amount of the aforementioned antioxidants (a) in the finished Preparations are e.g. B. 0.001 to 30 wt .-%, preferably 0.01 to 10% by weight and in particular 1 to 5% by weight.
Die erfindungsgemäßen kosmetischen und dermatologischen
Zubereitungen bieten einen wirksamen Schutz vor
- - oxidativen Prozessen,
- - durch Strahlung oder reaktiven Verbindungen hervorgerufenen Prozessen.
- - oxidative processes,
- - processes caused by radiation or reactive compounds.
Die neuen kosmetischen und dermatologischen Formulierungen können bezüglich ihrer anderen Bestandteile wie üblich zusammengesetzt sein und zur Behandlung, der Pflege und der Reinigung der Haut in der Kosmetik dienen. Die Zusammensetzung richtet sich dabei nach der Effektivität des Inhibitors, den Penetrationseigenschaften der Wirksubstanz durch das Stratum Corneum und ihrer Fähigkeit in der Haut ein Depot zu bilden. The new cosmetic and dermatological formulations can composed of their other components as usual be and for the treatment, care and cleaning of the skin in serve cosmetics. The composition depends on this the effectiveness of the inhibitor, the penetration properties the active substance through the stratum corneum and its ability to form a depot in the skin.
Überraschenderweise ist bei erfindungsgemäßer Anwendung der
Wirkstoffe bzw. Wirkstoffkombination eine kosmetisch wirksame
Behandlung aber auch Vorbeugung von
- - vorzeitig gealteter Haut (z. B. Falten, Altersflecken, Teleangiektasien, Pigmentstörungen) und/oder vorzeitig gealterten Hautanhangsgebilden
- - strahlungsbedingten Hautschäden oder strahlungsbedingten negativen Veränderungen der Haut und/oder der Hautanhangsgebilde
- - umweltbedingten (Ozon, freie Radikale, Singulettsauerstoff, reaktive Sauerstoff- oder Stickstoffverbindungen, Zigarettenrauch, Toxine) Hautschäden oder umweltbedingten negativen Veränderungen der Haut und/oder der Hautanhangsgebilde
- - lichtempfindlichen, entzündlichen, erythematösen, allergischen oder autoimmunreaktiven Veränderungen der Haut und/oder der Hautanhangsgebilde (insbesondere Akne, fettige oder trockene Haut, Keratosen, Rosaceae, Dermatosen, atopisches Ekzem, seborrhoisches Ekzem, Photodermatosen, polymorphe Lichtdermatose)
- - defizitären, sensitiven oder hypoaktiven Zuständen der Haut und/oder der Hautanhangsgebilde
- - Juckreiz sowie
- - trockenen Hautzuständen und Hornschichtbarrierestörungen
- - prematurely aged skin (e.g. wrinkles, age spots, telangiectasia, pigment disorders) and / or prematurely aged skin appendages
- - radiation-induced skin damage or radiation-related negative changes in the skin and / or the appendages of the skin
- - Environmentally related (ozone, free radicals, singlet oxygen, reactive oxygen or nitrogen compounds, cigarette smoke, toxins) skin damage or environmentally related negative changes in the skin and / or the appendages of the skin
- - Photosensitive, inflammatory, erythematous, allergic or autoimmune-reactive changes in the skin and / or the appendages of the skin (in particular acne, oily or dry skin, keratoses, rosaceae, dermatoses, atopic eczema, seborrheic eczema, photodermatoses, polymorphic light dermatosis)
- - deficient, sensitive or hypoactive conditions of the skin and / or the appendages of the skin
- - itching as well
- - Dry skin conditions and horny layer barrier disorders
Zur Anwendung werden die erfindungsgemäßen kosmetischen und dermatologischen Zubereitungen in der für Kosmetika üblichen Weise auf die Haut (und/oder die Haare) in ausreichender Menge aufgebracht. The cosmetic and dermatological preparations in the usual for cosmetics Apply to the skin (and / or hair) in sufficient quantities applied.
Beispielsweise werden die erfindungsgemäßen Wirkstoffe in kosmetischen Mitteln zur Reinigung der Haut, wie Stückseifen, Toilettenseifen, Kernseifen, Transparentseifen, Luxusseifen, Deoseifen, Cremeseifen, Babyseifen, Hautschutzseifen, Abrasivseifen, Syndets, flüssige Seifen, pastöse Seifen, Schmierseifen, Waschpasten, flüssige Wasch-, Dusch- und Badepräparaten z. B. Waschlotionen, Duschbädern, Duschgelen, Schaumbädern, Cremeschaumbädern, Ölbädern, Badeextrakten, Scrubpräparate, in-situ Produkte, Rasierschäumen, Rasierlotionen, Rasiercremes eingesetzt. For example, the active compounds according to the invention are described in cosmetic agents for cleaning the skin, such as bar soaps, Toilet soaps, core soaps, transparent soaps, luxury soaps, Deodorant soaps, cream soaps, baby soaps, skin protection soaps, abrasive soaps, Syndets, liquid soaps, pasty soaps, soft soaps, Washing pastes, liquid washing, showering and bathing preparations, e.g. B. Washing lotions, shower baths, shower gels, foam baths, Cream foam baths, oil baths, bath extracts, scrub preparations, in-situ Products, shaving foams, shaving lotions, shaving creams used.
Weiterhin eignen sie sich für hautkosmetische Zubereitungen wie W/O- oder O/W-Haut- und Körpercremes, Tag- und Nachtcremes, Lichtschutzmittel, After Sun Produkte, Handpflegeprodukte, Gesichtcremes, Multiple Emulsionen, Gelees, Mikroemulsionen, Liposomenpräparate, Niosomenpräparate, Antifaltencremes, Gesichtsöle, Lipogele, Sportgele, Feuchthaltecremes, Bleichcremes, Vitamincremes, Hautlotionen, Pflegelotionen, Ampullen, After Shave Lotionen, Pre-Shaves, Feuchthaltelotionen, Bräunungslotionen, Cellulitecremes, Depigmentierungsmittel, Massagepräparate, Körperpuder, Gesichtswasser, Deodorantien, Antitranspirantien, Nose-Strips, Antiaknemittel, Repellent und andere. They are also suitable for skin cosmetic preparations such as W / O or O / W skin and body creams, day and Night creams, sunscreens, after sun products, Hand care products, face creams, multiple emulsions, jellies, Microemulsions, liposome preparations, niosome preparations, Anti-wrinkle creams, facial oils, lipogels, sports gels, moisturizing creams, Bleaching creams, vitamin creams, skin lotions, skin care lotions, Ampoules, after shave lotions, pre-shaves, moisturizing lotions, Tanning lotions, cellulite creams, depigmenting agents, Massage preparations, body powder, facial tonic, deodorants, Antiperspirants, nose strips, antiacne agents, repellants and other.
Außerdem können die erfindungsgemäßen Wirkstoffe in kosmetischen Mitteln für die Haarpflege wie Haarkuren, Haarlotionen, Haarspülungen, Haaremulsionen, Spitzenfluids, Egalisierungsmittel für Dauerwellen, Hot-Oil-Treatmentpräparate, Conditioner, Festigerlotionen, Shampoos, Haartönungs- und Färbemittel, Haarsprays, Fönlotionen, -festiger, Glanzsprays, Haarbrillantine, Haarstylingprodukte, Haarwasser, Alopeciepflegemitteln und andere verwendet werden. In addition, the active compounds according to the invention can be used in cosmetic Hair care products such as hair treatments, hair lotions, Hair rinses, hair emulsions, tip fluids, leveling agents for Perms, hot oil treatment preparations, conditioners, Setting lotions, shampoos, hair tinting and coloring agents, hair sprays, Hair dryer lotions, lotions, gloss sprays, hair brilliants, Hair styling products, hair lotions, alopecia care products and others be used.
Die kosmetischen oder dermatologischen Zubereitungen können je nach Anwendungsgebiet als Spray (Pumpspray oder Aerosol), Schaum, Gel, Gelspray, Lotion, Creme, Mousse, Salbe, Suspensionen oder Pulver zubereitet werden. The cosmetic or dermatological preparations can each depending on the application as a spray (pump spray or aerosol), foam, Gel, gel spray, lotion, cream, mousse, ointment, suspensions or Powder can be prepared.
Es ist auch vorteilhaft, die Wirkstoffe in verkapselter Form darzureichen, z. B. als Celluloseverkapselung, in Gelatine, mit Polyamiden, in Niosomen, Wachsmatrices, mit Cyclodextrinen oder liposomal verkapselt. It is also advantageous to have the active ingredients in encapsulated form to present, e.g. B. as cellulose encapsulation, in gelatin, with Polyamides, in niosomes, wax matrices, with cyclodextrins or encapsulated liposomally.
Die erfindungsgemäßen Zubereitungen enthalten in Regel weitere Hilfsstoffe, wie sie üblicherweise in solchen Zubereitungen verwendet werden, z. B. Konservierungsmittel, Bakterizide, Parfüme, Substanzen zum Verhindern des Schäumens, Farbstoffe, Pigmente, Verdickungsmittel, oberflächenaktive Substanzen, Emulgatoren, weichmachende Substanzen, Avivagemittel, Fette, Öle, Wachse oder andere übliche Bestandteile einer kosmetischen oder dermatologischen Formulierung wie Alkohole, Polyole, Polymere, Schaumstabilisatoren, Lösungsvermittler, Elektrolyte, organische Säuren, organische Lösungsmittel oder Silikonderivate. The preparations according to the invention generally contain others Excipients, as are usually found in such preparations be used, e.g. B. preservatives, bactericides, perfumes, Anti-foaming agents, dyes, pigments, Thickeners, surface-active substances, emulsifiers, softening substances, softeners, fats, oils, waxes or other common ingredients of a cosmetic or dermatological formulation such as alcohols, polyols, polymers, Foam stabilizers, solubilizers, electrolytes, organic Acids, organic solvents or silicone derivatives.
Die erfindungsgemäßen Zubereitungen können zusätzlich zu den genannten Zusatzstoffen weitere Verbindungen enthalten, die antioxidativ, als Radikalfänger, hautbefeuchtend oder -feuchthaltend, antierythematös, antientzündlich oder antiallergisch wirken, um deren Wirkung zu ergänzen oder zu verstärken. Insbesondere können diese Verbindungen ausgewählt werden aus der Gruppe der Vitamine, Pflanzenextrakte, Alpha- und Betahydroxysäuren, Ceramide, anti-inflammatorischen, anti-mikrobiellen oder UV-filternden Substanzen, sowie deren Derivaten und Mischungen daraus. The preparations according to the invention can be used in addition to mentioned additives contain other compounds that antioxidant, as radical scavenger, skin moisturizing or -Humidifying, anti-inflammatory, anti-inflammatory or anti-allergic act to complement or reinforce their effect. In particular, these compounds can be selected from the Group of vitamins, plant extracts, alpha and Beta hydroxy acids, ceramides, anti-inflammatory, anti-microbial or UV filtering substances, as well as their derivatives and mixtures it.
Vorteilhaft können erfindungsgemäße Zubereitungen außerdem Substanzen enthalten, die UV-Strahlung im UV-B- und/oder UV-A- Bereich absorbieren. Preparations according to the invention can also be advantageous Contain substances that contain UV radiation in UV-B and / or UV-A Absorb area.
Die Lipidphase wird vorteilhaft gewählt aus der Substanzgruppe der Mineralöle, Mineralwachse, verzweigte und/oder unverzweigte Kohlenwasserstoffe und -wachse, Triglyceride gesättigter und/oder ungesättigter, verzweigter und/oder unverzweigter C8-C24 -Alkancarbonsäuren; sie können ausgewählt werden aus synthetischen, halbsynthetischen oder natürlichen Ölen wie Olivenöl, Palmöl, Mandelöl oder Mischungen; Öle, Fette oder Wachse, Ester aus gesättigten und/oder ungesättigten, verzweigten und/oder unverzweigten C3-C30-Alkancarbonsäuren und gesättigten und/oder ungesättigten, verzweigten und/oder unverzweigten C3-C30-Alkoholen, aus aromatischen Carbonsäuren und gesättigten und/oder ungesättigten, verzweigten und/oder unverzweigten C3-C30-Alkoholen, beispielhaft Isopropylmyristat, Isopropylstearat, Hexyldecylstearat, Oleyloleat; außerdem synthetische, halbsynthetische und natürliche Gemische solcher Ester wie Jojobaöl, Alkylbenzoate oder Silikonöle wie z. B. Cyclomethicon, Dimethylpolysiloxan, Diethylpolysiloxan, Octamethylcyclotetrasiloxan sowie Mischungen daraus oder Dialkylether. The lipid phase is advantageously selected from the group of substances of mineral oils, mineral waxes, branched and / or unbranched hydrocarbons and waxes, triglycerides of saturated and / or unsaturated, branched and / or unbranched C 8 -C 24 alkane carboxylic acids; they can be selected from synthetic, semi-synthetic or natural oils such as olive oil, palm oil, almond oil or mixtures; Oils, fats or waxes, esters from saturated and / or unsaturated, branched and / or unbranched C 3 -C 30 alkane carboxylic acids and saturated and / or unsaturated, branched and / or unbranched C 3 -C 30 alcohols, from aromatic carboxylic acids and saturated and / or unsaturated, branched and / or unbranched C 3 -C 30 alcohols, for example isopropyl myristate, isopropyl stearate, hexyldecyl stearate, oleyl oleate; also synthetic, semi-synthetic and natural mixtures of such esters such as jojoba oil, alkyl benzoates or silicone oils such as. B. cyclomethicone, dimethylpolysiloxane, diethylpolysiloxane, octamethylcyclotetrasiloxane and mixtures thereof or dialkyl ether.
Die wässrige Phase der erfindungsgemäßen Zubereitungen enthält gegebenenfalls vorteilhaft Alkohole, Diole oder Polyole niedriger C-Zahl, sowie deren Ether, vorzugsweise Ethanol, Isopropanol, Propylenglykol, Glycerin, Ethylenglykolmonoethylether. The aqueous phase of the preparations according to the invention contains optionally advantageous alcohols, diols or polyols lower Carbon number, and their ethers, preferably ethanol, isopropanol, Propylene glycol, glycerin, ethylene glycol monoethyl ether.
Als Emulgatoren kommen vorzugsweise bekannte W/O- daneben aber auch O/W-Emulgatoren wie Polyglycerinester, Sorbitanester oder teilveresterte Glyceride in Betracht. Known W / O- are preferably used as emulsifiers also O / W emulsifiers such as polyglycerol esters, sorbitan esters or partially esterified glycerides into consideration.
Als geeignete Lösungsvermittler sind insbesondere ethoxylierte Sorbitanester, ethoxylierte Lanolinalkohole und ethoxyliertes Rizinusöl zu nennen. Particularly suitable solubilizers are ethoxylated ones Sorbitan esters, ethoxylated lanolin alcohols and ethoxylated To call castor oil.
Übliche native und synthetische Verdickungsmittel bzw. Gelbildner in Formulierungen sind vernetzte Polyacrylsäuren und deren Derivate, Polysaccharide wie Xanthan Gum oder Alginate, Carboxymethylcellulose oder Hydroxycarboxymethylcellulose, Hydrokolloide wie Gummi Arabicum oder Motmorillonitmineralien wie Bentonite oder Fettalkohole, Polyvinylalkohol und Polyvinylpyrrolidon. Usual native and synthetic thickeners or gel formers in formulations are cross-linked polyacrylic acids and their Derivatives, polysaccharides such as xanthan gum or alginates, Carboxymethyl cellulose or hydroxycarboxymethyl cellulose, hydrocolloids such as gum arabic or motmorillonite minerals such as bentonite or fatty alcohols, polyvinyl alcohol and polyvinyl pyrrolidone.
Als Treibmittel für erfindungsgemäße Aerosole kommen die üblichen Treibmittel in Frage, beispielhaft Propan, Butan, Pentan und andere. The usual propellants for aerosols according to the invention Propellants in question, for example propane, butane, pentane and other.
Gemäß der im folgenden angegebenen Versuchsanordnung wurden die in der Tabelle 1 und 2 aufgeführten erfindungsgemäß zu verwendenden Verbindungen im Vergleich zu Cystin und Cystein auf ihre Peroxid-zersetzende Wirkung untersucht. According to the experimental setup given below according to the invention listed in Tables 1 and 2 using compounds compared to cystine and cysteine investigated their peroxide-decomposing effect.
Folgende Lösungen wurden hergestellt:
- 1. 0,05 molare Lösung von tert.-Butylhydroperoxid in CD3COOD
- 2. 0,055 molare Lösung des potentiellen Hydroperoxid-Zersetzers in CD3COOD
- 1. 0.05 molar solution of tert-butyl hydroperoxide in CD 3 COOD
- 2. 0.055 molar solution of the potential hydroperoxide decomposer in CD 3 COOD
Daraus wurden die Messlösungen durch Mischen von 350 µl der Lösung 1 und 350 µl der jeweiligen Lösung 2 hergestellt; die Messlösung wurde dann in ein NMR-Röhrchen gegeben und in das NMR-Gerät transferiert. Herstellen der Lösungen und Durchführung der Messungen erfolgte stets bei 22°C. Vor der Messung wurden die Lösungen in einem Thermostaten bei 70°C für 30 Minuten gelagert. Alle Messungen wurden an dem 500 MHz-NMR-Spektrometer INOVA 500 der Fa. Varian durchgeführt. Von jeder Messlösung wurde ein 1H-NMR-Spektrum und ein 2D-HSQC (1H/13C)-Spektrum aufgenommen. Tert.-Butylhydroperoxid und tert.-Butanol wiesen jeweils sehr dicht beieinanderliegende CH3-Protonen-Signale auf; die Zuordnung der Signale zu tBuOOH bzw. tBuOH erfolgte anhand der 2D-HSQC- Spektren. Die relativen Anteile der beiden Komponenten wurden durch Integration über das Signal der entsprechenden Komponenten im 1H-Spektrum oder der Kreuzpeaks im HSQC-Spektrum ermittelt (Lit: W. Wilker et al. Magn. Reson. Chem. 31, 287-292 (1993)). The measuring solutions were prepared from this by mixing 350 µl of solution 1 and 350 µl of the respective solution 2; the measurement solution was then placed in an NMR tube and transferred to the NMR device. The solutions were always prepared and the measurements were carried out at 22 ° C. Before the measurement, the solutions were stored in a thermostat at 70 ° C for 30 minutes. All measurements were carried out on the INOVA 500 500 MHz NMR spectrometer from Varian. A 1 H-NMR spectrum and a 2D-HSQC ( 1 H / 13 C) spectrum were recorded from each measurement solution. Tert.-butyl hydroperoxide and tert.-butanol each had very closely spaced CH 3 proton signals; the signals were assigned to tBuOOH or tBuOH using the 2D HSQC spectra. The relative proportions of the two components were determined by integration via the signal of the corresponding components in the 1 H spectrum or the cross peaks in the HSQC spectrum (Lit: W. Wilker et al. Magn. Reson. Chem. 31, 287-292 (1993 )).
Es wurden jeweils 350 µl von 0174 (A80) und 350 µl der anderen
Proben gemischt. Als LM wurde Toluene-d8 (=N) oder CD3COOD (=S)
verwendet.
Beispiele
Beispiele kosmetischer Zubereitungen
Examples Examples of cosmetic preparations
Claims (16)
einsetzt, in der die Variablen unabhängig voneinander folgende Bedeutung haben:
R1, R2 und R3:
Wasserstoff, C1-C20-Alkyl, C2-C10-Alkenyl, C3-C10-Cycloalkyl, C3-C10-Cycloalkenyl, C1-C12-Alkoxy, C1-C20-Alkoxycarbonyl, C1-C12-Alkylamino, C1-C12-Dialkylamino, Aryl, Heteroaryl, gegebenenfalls substituiert. 9. Boron-containing compound according to one of the preceding claims, characterized in that a compound of the formula (I)
in which the variables have the following meaning independently of one another:
R 1 , R 2 and R 3 :
Hydrogen, C 1 -C 20 alkyl, C 2 -C 10 alkenyl, C 3 -C 10 cycloalkyl, C 3 -C 10 cycloalkenyl, C 1 -C 12 alkoxy, C 1 -C 20 alkoxycarbonyl, C 1 -C 12 alkylamino, C 1 -C 12 dialkylamino, aryl, heteroaryl, optionally substituted.
einsetzt, in der R1 die oben angegebene Bedeutung besitzt. 10. Boron-containing compound according to one of the preceding claims, characterized in that a compound of formula (II)
used, in which R 1 has the meaning given above.
einsetzt, in der R1 und R2 die oben angegebene Bedeutung besitzen. 11. Boron-containing compound according to one of the preceding claims, characterized in that a compound of formula (III)
used, in which R 1 and R 2 have the meaning given above.
einsetzt, in der R1 und R2 die oben angegebene Bedeutung besitzen und R1 und R2 durch Ringschluss verbrückt sein können. 12. Boron-containing compound according to one of the preceding claims, characterized in that a compound of the formula (IV)
uses, in which R 1 and R 2 have the meaning given above and R 1 and R 2 may be bridged by ring closure.
einsetzt, in der R1, R2 und R3 die oben angegebenen Bedeutungen besitzen. 13. Boron-containing compound according to one of the preceding claims, characterized in that a compound of the formula (V)
used, in which R 1 , R 2 and R 3 have the meanings given above.
einsetzt, in der R1, R2 und R3 die oben angegebenen Bedeutungen besitzen. 14. Boron-containing compound according to one of the preceding claims, characterized in that a compound of the formula (VI)
used, in which R 1 , R 2 and R 3 have the meanings given above.
einsetzt, in der R1, R2 und R3 die oben angegebenen Bedeutungen besitzen. 15. Boron-containing compound according to one of the preceding claims, characterized in that a compound of formula (VII)
used, in which R 1 , R 2 and R 3 have the meanings given above.
einsetzt, in der die Variablen unabhängig voneinander die folgende Bedeutung haben:
R1, R2, R3 und R4
Wasserstoff, C1-C20-Alkyl, C2-C10-Alkenyl, C3-C10 -Cycloalkyl, C3-C10-Cycloalkenyl, C1-C12-Alkoxy, C1-C20 -Alkoxycarbonyl, C1-C12-Alkylamino, C1-C12-Dialkylamino, Aryl, Heteroaryl, gegebenenfalls substituiert
X⊕ physiologisch verträgliche Kationen, wie die Alkali- und Erdalkalisalze oder wie gegebenenfalls substituierte Ammoniumsalze. 16. Boron-containing compound according to one of the preceding claims, characterized in that a compound of the formula (VIII)
where the variables have the following meaning independently of one another:
R 1 , R 2 , R 3 and R 4
Hydrogen, C 1 -C 20 alkyl, C 2 -C 10 alkenyl, C 3 -C 10 cycloalkyl, C 3 -C 10 cycloalkenyl, C 1 -C 12 alkoxy, C 1 -C 20 alkoxycarbonyl, C 1 -C 12 alkylamino, C 1 -C 12 dialkylamino, aryl, heteroaryl, optionally substituted
X⊕ physiologically compatible cations, such as the alkali and alkaline earth metal salts or as optionally substituted ammonium salts.
Priority Applications (9)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE2002102065 DE10202065A1 (en) | 2002-01-18 | 2002-01-18 | Use of organoboron compounds capable of reducing (hydro)peroxides to alcohols in cosmetic or dermatological compositions useful for preventing or treating (hydro)peroxide-induced skin damage |
| EP03704347A EP1469822A2 (en) | 2002-01-18 | 2003-01-03 | Cosmetic or dermatological preparations for preventing damages to skin caused by peroxides |
| CNA038023377A CN1617706A (en) | 2002-01-18 | 2003-01-03 | Cosmetic or dermatological preparations for preventing damages to skin caused by peroxides |
| US10/500,459 US20050118209A1 (en) | 2002-01-18 | 2003-01-03 | Cosmetic or dermatological preparations for preventing damages to skin caused by peroxides |
| AU2003206690A AU2003206690A1 (en) | 2002-01-18 | 2003-01-03 | Cosmetic or dermatological preparations for preventing damages to skin caused by peroxides |
| MXPA04006489A MXPA04006489A (en) | 2002-01-18 | 2003-01-03 | Cosmetic or dermatological preparations for preventing damages to skin caused by peroxides. |
| JP2003559476A JP2006502962A (en) | 2002-01-18 | 2003-01-03 | Cosmetic or dermatological preparation for preventing skin damage caused by peroxide |
| CA002471712A CA2471712A1 (en) | 2002-01-18 | 2003-01-03 | Cosmetic or dermatological preparations for preventing damages to skin caused by peroxides |
| PCT/EP2003/000014 WO2003059312A2 (en) | 2002-01-18 | 2003-01-03 | Cosmetic or dermatological preparations for preventing damages to skin caused by peroxides |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE2002102065 DE10202065A1 (en) | 2002-01-18 | 2002-01-18 | Use of organoboron compounds capable of reducing (hydro)peroxides to alcohols in cosmetic or dermatological compositions useful for preventing or treating (hydro)peroxide-induced skin damage |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DE10202065A1 true DE10202065A1 (en) | 2003-07-24 |
Family
ID=7712627
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DE2002102065 Withdrawn DE10202065A1 (en) | 2002-01-18 | 2002-01-18 | Use of organoboron compounds capable of reducing (hydro)peroxides to alcohols in cosmetic or dermatological compositions useful for preventing or treating (hydro)peroxide-induced skin damage |
Country Status (1)
| Country | Link |
|---|---|
| DE (1) | DE10202065A1 (en) |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE102004009152A1 (en) * | 2004-02-23 | 2005-09-01 | Beiersdorf Ag | Using ascorbic acid and its derivatives for treating teleangiektasia and vascular slackness, and for tightening superficial blood vessels |
| CN114824475A (en) * | 2022-04-12 | 2022-07-29 | 华南师范大学 | Electrolyte containing 3-isopropylbenzene boric acid ethylene glycol ester additive and preparation and application thereof |
-
2002
- 2002-01-18 DE DE2002102065 patent/DE10202065A1/en not_active Withdrawn
Cited By (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE102004009152A1 (en) * | 2004-02-23 | 2005-09-01 | Beiersdorf Ag | Using ascorbic acid and its derivatives for treating teleangiektasia and vascular slackness, and for tightening superficial blood vessels |
| CN114824475A (en) * | 2022-04-12 | 2022-07-29 | 华南师范大学 | Electrolyte containing 3-isopropylbenzene boric acid ethylene glycol ester additive and preparation and application thereof |
| CN114824475B (en) * | 2022-04-12 | 2024-11-26 | 华南师范大学 | An electrolyte containing 3-isopropylphenylboronic acid ethylene glycol ester additive and its preparation and application |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP1469822A2 (en) | Cosmetic or dermatological preparations for preventing damages to skin caused by peroxides | |
| EP1307179A2 (en) | Cosmetic or dermatological preparations for avoiding skin damage caused by peroxide | |
| DE4228455A1 (en) | Cosmetic and dermatological sunscreen formulations containing thiols and / or thiol derivatives | |
| DE10064818A1 (en) | Use of chroman derivatives in cosmetic or dermatological preparations | |
| EP0726273A1 (en) | Tocophenylglycoxides, their preparation and use as tensides, as antioxidants and as cells altering prophylactics in cosmetic or pharmaceutical preparation | |
| DE10132338A1 (en) | Use of 5'-deoxy-5'-methylthioadenosine in skin cosmetic products | |
| EP1066821A1 (en) | Topical cosmetic product containing benzaldoxims | |
| DE10032165A1 (en) | Use of physiologically tolerable sulfinic acids as antioxidant or free radical scavenger in cosmetic or dermatological preparations | |
| DE4434312A1 (en) | Antimycotic cosmetic and dermatological compsns. | |
| EP2090290B1 (en) | Use of 3-(4-hydroxy-3-methoxyphenyl)-1-(4-hydroxphenyl)-propan-1-on for improved skin contouring and countering cellulite | |
| DE10202065A1 (en) | Use of organoboron compounds capable of reducing (hydro)peroxides to alcohols in cosmetic or dermatological compositions useful for preventing or treating (hydro)peroxide-induced skin damage | |
| EP0744175A2 (en) | Cosmetic or dermatological compositions containing alpha-hydroxy fatty acids | |
| DE4405585C2 (en) | Use of trans-urocanic acid for the treatment or prophylaxis of oxidative stress induced skin aging | |
| EP0706786A2 (en) | Use of chlorogenic acid as antioxidant in cosmetic, especially haircosmetic compositions, and compositions containing chlorogenic acid | |
| EP1781236A1 (en) | Cosmetic compositions comprising specific cyclohexanmono-, -di- or -triols or cyclohexyl methan- or -ethan- or -propoanols | |
| EP1881817A2 (en) | Use of peroxide decomposers in cosmetic and pharmaceutical agents for treating skin | |
| DE60118196T2 (en) | USE OF A LIPONIC ACID (R) -ENANTIOMER IN COSMETICS AND DERMATOLOGY | |
| DE102008009799B4 (en) | Use of 3- (4-hydroxy-3-methoxyphenyl) -1- (4-hydroxyphenyl) -propan-1-one against hyperpigmentation | |
| DE10010814A1 (en) | Cosmetic preparations containing new or known 4-oxoretinol compounds, useful for prophylaxis of aging of the skin or hair | |
| EP1945308A1 (en) | Topically applicable composition for use as a skin bleaching agent | |
| WO2002078686A1 (en) | Retinyl carbonates in cosmetic and dermatological preparations | |
| DE102008009750A1 (en) | Cosmetic or dermatological preparations containing 3- (4-hydroxy-3-methoxyphenyl) -1- (4-hydroxyphenyl) -propan-1-one and one or more polyols | |
| EP2090288B1 (en) | Cosmetic or dermatological preparations with a 3-(4-hydroxy-3-methoxyphenyl)-1-(4-hydroxphenyl)-propan-1-on content and one or more cinnamon acid derivatives | |
| EP2090289B1 (en) | Cosmetic or dermatological preparations with a 3-(4-hydroxy-3-methoxyphenyl)-1-(4-hydroxphenyl)-propan-1-on content and ethylhexyl-2-cyano-3, 3-diphenylacrylate | |
| CH703818A2 (en) | Agent, useful e.g. useful as a skin brightening agent, sunscreens, deodorants and soaps and for bleaching age and pigment spots, comprises a disulfide compound or its acid addition salt |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| 8130 | Withdrawal |